Iron is a versatile redox-active catalyst and a required cofactor within a diverse array of biological processes. To almost all organisms, iron is both essential and potentially toxic, where homeostatic concentrations must be stringently maintained. Within the iron-restricted host, the survival and proliferation of microbial invaders is contingent upon exploiting the host iron pool. Bacteria express a multitude of complex, and often redundant means of acquiring iron, including surface-associated heme-uptake pathways, high affinity iron-scavenging siderophores and transporters of free inorganic iron. Within the last decade, our understanding of iron acquisition by Gram-positive pathogens has expanded substantively, from the discovery of the iron-regulated surface-determinant pathway and numerous unique siderophores through to the detailed elucidation of heme-iron extraction, and heme and siderophore coordination and transfer. This review provides a comprehensive summary of the iron acquisition strategies of notorious Gram-positive pathogens and highlights how both conserved and distinct tactics for acquiring iron contribute to the pathophysiology of these bacteria. Further, a focus on recent structural and mechanistic studies details how these iron acquisition systems may be exploited in the development of novel therapeutics.
INTRODUCTION
Iron is an essential micronutrient for eukaryotes and prokaryotes alike. The indispensable nature of iron is due to its involvement in several key metabolic processes including amino acid synthesis, tricarboxylic acid (TCA) cycle activity, DNA replication, cellular respiration and electron transport. Iron is imparted with impressive catalytic versatility due to its ability to participate in single electron transfers as it interconverts between the Fe 3+ (ferric) and Fe 2+ (ferrous) redox states. However, this activity is also capable of promoting unfavorable interactions that generate toxic reactive oxygen species (ROS) through
Fenton chemistry and the Haber-Weiss reaction (Fenton 1894; Haber and Weiss 1932) . The iron-catalyzed generation of ROS, including hydroxyl radicals, hydrogen peroxide and superoxide anions, can compromise cell viability by inflicting damage upon lipids, proteins and nucleic acids (Imlay and Linn 1988; McManus and Josephy 1995; Cabiscol, Tamarit and Ros 2000; Imlay 2002 ). As such, a delicate balance exists in aerobic organisms between the acquisition of iron for essential cellular processes and the sequestration of iron to avoid toxicity. By mass, iron is the most abundant element on Earth. However, owing to its insolubility under physiological conditions and consequent formation of ferric oxyhydroxide precipitates, free bioavailable iron in solution is extremely limited (10 −8 -10
M), and well below the range that supports microbial growth (∼10 −6 M) (Ratledge and Dover 2000) . Iron within the host is further restricted (up to 10 −24 M), in an effort to suppress the generation of ROS and to help ensure bacteriostasis at potential sites of infection (Bullen 1981; Raymond, Dertz and Kim 2003; Ratledge 2007) . The withholding of metals, such as iron, to effectively starve pathogens of essential elements is referred to as 'nutritional immunity' (Kochan 1973; Weinberg 1974 Weinberg , 1975 , and is an important facet of the host innate immune defense. Both nutritional immunity and host iron homeostasis have been extensively reviewed elsewhere, and thus critical determinants of these processes are summarized in Table 1 (for a comprehensive discussion, see Cassat and Skaar 2013) . The paucity of available iron within the host has ultimately instigated an evolutionary war between hosts and pathogens, where successful invaders express a diverse complement of mechanisms for exploiting the host iron pool and circumventing nutritional immunity. The identification and characterization of iron acquisition systems in the Grampositive pathogens has largely occurred within the last decade, and includes cell-surface-associated heme-iron extraction and transfer mechanisms to obtain heme from hemoproteins, the elaboration of high-affinity iron-scavenging siderophores to pillage iron from transferrin and lactoferrin, receptors to expropriate siderophores from heterologous bacteria, and ferric iron reductases and transporters for the acquisition of free inorganic iron. While many of these systems are highly conserved between diverse genera of bacteria, others are constrained to specific pathogenic species and are a reflection of both their unique pathophysiology and preferred host niches. 
Cell-associated transporters and enzymes

Ferrireductase
Reduces dietary ferric iron to ferrous iron for uptake by duodenal enterocytes. Divalent metal ion transporter (DMT1; aka Nramp2 or DCT1)
Mediates ferrous iron uptake by duodenal enterocytes and macrophages; mediates export of iron released from transferrin within endosomes.
Transferrin receptor (Tfr1 and Tfr2)
Mediates the endocytosis of holo-transferrin.
Ferrireductase STEAP3
Reduces ferric iron within the acidified endosome to facilitate iron release from transferrin.
Ferroportin
Transports iron out of enterocytes and macrophages and into the plasma.
Hephaestin
Oxidizes ferrous iron to ferric iron at the enterocyte plasma membrane allowing for sequestration by transferrin (also performed by circulating ceruloplasmin).
Nramp1
Transports iron (and other divalent metals) out of phagosomal compartment, thus limiting metal availability to intracellular pathogens; contributes to the acidification of the phagosome.
Regulatory hormone
Hepcidin Binds ferroportin on enterocytes and macrophages leading to its internalization and degradation; mediates the 'hypoferremia of infection' by limiting iron release from macrophages in response to inflammation.
Intracellular iron storage
Ferritin Provides intracellular iron storage.
Extracellular iron carriers
Transferrin Binds free ferric iron within the serum and transports it to target tissues. Lactoferrin Sequesters and transports free ferric iron at mucosal surfaces and in secretions; released from neutrophil secondary granules at sites of inflammation. Haptoglobin Scavenges free extracellular hemoglobin released upon erythrocyte lysis; haptoglobin-hemoglobin complexes are endocytosed and metabolized by macrophages. Hemopexin Scavenges free extracellular heme released upon erythrocyte lysis; heme-hemopexin complexes are endocytosed and metabolized by macrophages. Serum albumin Abundant plasma protein; binds free heme released into the bloodstream (particularly after acute hemolysis), and gradually transfers it to hemopexin. Siderocalin Sequesters catecholate bacterial siderophores; serum concentrations are increased in response to bacterial infection.
2,5-dihydroxybenzoic acid
Functions as a mammalian siderophore-like molecule to sequester extracellular iron (may itself be used as a bacterial iron source).
a Host iron homeostasis and nutritional immunity have been extensively summarized elsewhere; for a comprehensive discussion, the readers are referred to recent reviews by Cassat and Skaar (2013) and Nairz et al. (2014) and the references therein.
Since a prior review on this topic over 10 years ago , the field has advanced considerably. In this review, we have undertaken a comprehensive examination of the past decade of literature detailing the iron acquisition strategies of notorious Gram-positive pathogens including Staphylococcus spp., Streptococcus spp., Bacillus spp., Listeria monocytogenes and Corynebacterium diphtheriae. Extensively characterized archetypal iron acquisition systems are contrasted with the unique or novel methods specific pathogens employ to obtain iron within the host. Recent insights have provided structural and mechanistic details into how host iron substrates are accessed, coordinated and transferred by Grampositive pathogens and are highlighted herein. The identification of highly expressed and/or conserved iron acquisition mechanisms has provided a framework for the specific targeting of these pathogens. Current and future directions towards the development of novel therapeutics are discussed.
TRANSCRIPTIONAL REGULATION OF IRON HOMEOSTASIS IN GRAM-POSITIVE PATHOGENS
Iron starvation is a major sensory cue to many bacterial pathogens that results in global gene expression changes that are mediated by highly conserved transcriptional regulators. In the low G+C content Firmicutes including Staphylococcus spp., Bacillus spp. and L. monocytogenes, iron homeostasis is governed by the ferric uptake regulator, Fur (Escolar, Pérez-Martin and de Lorenzo 1999; Xiong et al. 2000; Ollinger et al. 2006; Ledala et al. 2007 Ledala et al. , 2010 ; Torres et al. 2010) , whereas in the high G+C content Actinomycetes, such as C. diphtheriae, this function is performed by the diphtheria toxin repressor, DtxR (Boyd, Oza and Murphy 1990; Schmitt and Holmes 1991; Holmes 2000; Schmitt 2003, 2005) . Streptococcus pyogenes utilizes a divergent DtxR homolog, the metal transporter of streptococci regulator, MtsR, in the control of iron uptake and virulence gene expression (Bates et al. 2005; Hanks et al. 2006; Toukoki et al. 2010) . Streptococcus mutans uses the manganese-dependent DtxR homolog, SloR, to regulate the expression of virulence genes (Rolerson et al. 2006; O'Rourke et al. 2010) , although its role in iron sensing and regulation of iron transport processes is still undetermined. Despite possessing low overall sequence homology, Fur, DtxR and MtsR are structurally and functionally analogous in that each is a homodimeric metalloprotein which functions largely as a transcriptional repressor of iron-responsive genes. Each protein monomer possesses a winged helix-turn-helix DNA recognition motif, a dimerization domain and a metalloregulatory site for binding of a metal (ferrous iron) corepressor (White et al. 1998; Escolar, Pérez-Martin and de Lorenzo 1999; Baichoo and Helmann 2002; Guedon and Helmann 2003; Bates et al. 2005) . Broadly, under iron-replete conditions, the association of iron with each subunit of the protein dimer yields a complex competent for DNA binding, which then interacts with a consensus motif located within the promoter/operator region of the target gene (de Lorenzo et al. 1987; Boyd, Oza and Murphy 1990; Escolar, Pérez-Martin and de Lorenzo 1999; Horsburgh, Ingham and Foster 2001; Baichoo and Helmann 2002; Bates et al. 2005; Toukoki et al. 2010) . Polymerization of this Fur-Fe 2+ , DtxR-Fe 2+ or MtsR-Fe 2+ complex with the operator region blocks access of RNA polymerase to the promoter, effectively inhibiting transcription. During iron starvation, iron dissociates from the metalloregulatory protein, resulting in dissociation of the complex and alleviation of the transcriptional repression of genes involved in the acquisition of iron, as well as numerous other virulence factors (Boyd, Oza and Murphy 1990; Holmes 2000; Bates et al. 2005; Torres et al. 2010; Toukoki et al. 2010; Johnson et al. 2011) . Unless otherwise noted, all of the iron acquisition strategies detailed below, and summarized in Table 2 , are subject to regulation by Fur, DtxR or MtsR.
HEME-IRON ACQUISITION STRATEGIES
For every tactic employed by the host to sequester iron, examples exist of sophisticated means by which pathogens subvert these withholding strategies. In broad terms, bacterial iron acquisition systems can be delineated by the iron source exploited, such as the intracellular oxygen carrying hemoproteins and storage protein ferritin, and the extracellular iron carrying/sequestering glycoproteins lactoferrin and transferrin. For invading pathogens, heme is a lucrative, and in the case of Staphylococcus aureus, preferred source of iron . Heme accounts for approximately 75% of the total iron pool within the mammalian host, and is found primarily in association with hemoglobin in circulating erythrocytes (Stojiljkovic and Perkins-Balding 2002) . Numerous Gram-positive pathogens, including Staphylococcus spp., Streptococcus spp., L. monocytogenes and Bacillus spp. secrete hemolysins (Parrisius et al. 1986; Nizet 2002; Shannon et al. 2003; Vandenesch, Lina and Henry 2012) , that facilitate the release of hemoglobin through erythrocyte lysis. Notably, these hemolysins are often expressed in response to iron deprivation or growth in human blood Malachowa and DeLeo 2011; Sineva et al. 2012; Tran et al. 2013) , and promote survival within the iron-restricted host. As detailed in Table 1 , free heme and hemoglobin are rapidly sequestered by host hemopexin and haptoglobin, respectively, so pathogens compete not only for free heme and hemoglobin but may also be capable of capturing heme-hemopexin (Fournier, Smith and Delepelaire 2011) and hemoglobin-haptoglobin (Dryla et al. 2007; Watanabe et al. 2008) complexes through the use of high-affinity heme-iron acquisition systems. In the following, we discuss important advancements in our knowledge of the molecular and mechanistic underpinnings of heme-iron acquisition by major Gram-positive pathogens. Since much of what is known comes from many studies performed in St. aureus, we will first discuss heme-iron acquisition in this pathogen before then comparing and contrasting with systems characterized in other staphylococcal species and other genera.
IRON-REGULATED SURFACE DETERMINANT PATHWAY
The St. aureus paradigm
The iron-regulated surface-determinant pathway (Isd) of St. aureus is the most extensively characterized heme-iron acquisition system of Gram-positive pathogens, and herein will be discussed as the archetype for orthologous mechanisms that transfer extracted heme, intact, from the cell surface to the cytoplasm. Staphylococcus aureus is a notorious Gram-positive pathogen, often regarded as the leading cause of infections of the skin and soft tissue (SSTI), respiratory tract and bloodstream (Moet et al. 2007 ). The success of St. aureus as a pathogen is partly attributable to its ability to exploit multiple sources of iron within the host, including transferrin and lactoferrin, free inorganic iron, and heme and hemoproteins (reviewed in Beasley and Heinrichs 2010; Haley and Skaar 2012; Hammer and Skaar 2012). In St. aureus, Isd is comprised of nine iron-regulated proteins directly involved in heme-iron acquisition, and sortase B (SrtB) which is also encoded from within the Isd locus (Mazmanian et al. 2002 (Mazmanian et al. , 2003 . In brief, three heme-binding proteins, IsdB, IsdH/HarA and IsdA, are covalently anchored to peptidoglycan by sortase A (SrtA) (Marraffini et al. 2004 ) while a fourth, IsdC, is tethered by its C-terminus to the cell wall by SrtB (Mazmanian et al. 2002 (Mazmanian et al. , 2003 Zong et al. 2004; Marraffini and Schneewind 2005) . The proposed architectural arrangement of these cell-wall-anchored proteins (see Fig. 1 ) bears resemblance to a funnel, and extensive experimental evidence suggests that heme extracted from hemoproteins bound by IsdB and IsdH at the cell surface is relayed through the cell wall by IsdA and IsdC. IsdC effectively serves as the central conduit through which heme is directed to the substrate-binding lipoprotein, IsdE (Muryoi et al. 2008; Tiedemann, Heinrichs and Stillman 2012) , and its associated membrane permease, IsdF. IsdE and IsdF are both components of an ABC transporter (Grigg et al. 2007b; Pluym et al. 2007 ), whose activity is powered by an undefined ATPase. IsdD is a predicted membrane protein purportedly functioning in conjunction with IsdEF; however, a role for this protein in heme translocation has not been conclusively determined and homologs of isdD are absent from the genomes of other Gram-positive pathogens. Once internalized, heme is degraded by one of two heme monooxygenases, IsdG or IsdI, releasing free iron from the tetrapyrrole ring for use by the bacterium (Skaar, Gaspar and Schneewind 2004; Wu et al. 2004 ).
Structure and function of NEAT domains
The binding of hemoproteins, extraction of heme and subsequent shuttling of heme through the cell wall by Isd proteins is facilitated by NEAr iron Transporter (NEAT) domains, Figure 1 . Staphylococcus aureus iron-regulated surface-determinant (Isd) schematic. Hemoglobin tetramers are bound by IsdH NEAT domains 1 and 2, and IsdB NEAT domain 1. Heme is extracted and bound by the heme-binding NEAT domains (IsdH NEAT-3 and IsdB NEAT-2), before being passaged through IsdA and IsdC to IsdE at the bacterial membrane. After IsdF-dependent translocation through the membrane, cytosolic heme may be degraded by heme monooxygenases IsdG and IsdI. The ribbon diagrams of PDB 2ITF (IsdA) and PDB 2Q7A (Shp) illustrate the structures, colored from the N-terminus (blue) to the C-terminus (red). Heme bound by the domains, as well as the key iron-coordinating tyrosine and stabilizing tyrosine residues in IsdA and methionine residues in Shp, are shown as sticks, with carbon, nitrogen, oxygen and sulfur colored yellow, blue, red and dark yellow, respectively. The iron in heme is shown as a red sphere.
so termed for their initial identification in proteins whose genes are located in proximity to others encoding putative ferric iron transporters (Andrade et al. 2002) . NEAT domains are heme and/or hemoprotein-binding modules consisting of ∼120 residues which, while variable in primary amino acid sequence, are highly conserved in secondary structure (Honsa, Maresso and Highlander 2014) . The canonical NEAT domain adopts an immunoglobulin-like sandwich fold, comprised of eight antiparallel β-strands and a conserved SXXXXY sequence which forms a 3 10 -helix (α-helix) referred to as the 'lip' region (Pilpa et al. 2006; Grigg et al. 2007a; Sharp et al. 2007; Villareal et al. 2008; Watanabe et al. 2008; Gaudin et al. 2011; Honsa, Maresso and Highlander 2014) . Heme coordination occurs between one of the β-strands (β8), which contains an essential YXXXY hemebinding motif, and the lip region, where the first tyrosine of the heme-binding motif (e.g. Y166 of IsdA) non-covalently binds the central iron atom of heme, and the second tyrosine residue (e.g. Y170 of IsdA) provides a stabilizing hydrogen bond to the first tyrosine ( Fig. 2) (Grigg et al. 2007a; Sharp et al. 2007; Villareal et al. 2008; Watanabe et al. 2008) . Together these interactions facilitate strong coordination of heme within the NEAT domain, where conservation of the first tyrosine serves as a predictor of NEAT domain function in heme binding (Grigg et al. 2007a ). While NEAT domains have been most extensively characterized in Gram-positive pathogens including St. aureus, S. pyogenes, Bacillus anthracis, B. cereus and L. monocytogenes, a recent bioinformatics study has revealed that they are widely distributed within the phylum Firmicutes, and are present in both pathogenic and non-pathogenic organisms (Honsa, Maresso and Highlander 2014) . In addition to their phylogenetic distribution, NEAT domains are also found distributed in variable number (one to five) within individual heme-binding proteins. In St. aureus, IsdB and IsdH possess two and three NEAT domains, respectively, whereas IsdA and IsdC each possess one (Figs 1 and 3A) (Pilpa et al. 2006; Grigg et al. 2007a; Sharp et al. 2007; Villareal et al. 2008; Watanabe et al. 2008; Gaudin et al. 2011) . Individual NEAT domains have also evolved different functionality within the same protein, as dictated by variability in their amino acid sequence or protein structure, and may include roles in Figure 4 . Heme release from hemoglobin requires multiple domains. In panel A is a ribbon diagram illustrating the structure of the linker region that resides between IsdH NEAT domains 2 and 3, as determined by NMR (PDB 2LHR). Panel B is a model of IsdH-or IsdB-dependent heme extraction from Hb tetramers. Subsequent to binding to the α subunit of Hb, the IsdH or IsdB NEAT domains, linked by the linker region, put strain on the tetramers, causing their dissociation and the loss of heme, which is picked up by the C-terminally located, heme-binding NEAT domain present in each of the proteins. Please note that this process, as shown, has not been experimentally proven.
hemoprotein binding, heme extraction, heme transfer with the same protein and/or heme transfer to other NEAT domaincontaining proteins mediated by protein-protein interactions.
The initial recognition and binding of hemoglobin in St. aureus is mediated by IsdB and IsdH (Torres et al. 2006; Dryla et al. 2007; Pishchany et al. 2014) . The N-terminal NEAT domains of these proteins are specific for hemoglobin (or hemoglobinhaptoglobin) (Dryla et al. 2003 (Dryla et al. , 2007 Pilpa et al. 2009; Visai et al. 2009; Dickson et al. 2014) where IsdB-N1 and IsdH-N2 can bind both subunits of the hemoglobin heterodimer or tetramer (αHb and βHb), while IsdH-N1 binds only αHb (Fig. 4) (Pilpa et al. 2006; Krishna Kumar et al. 2011; Bowden et al. 2014) . Hemoglobin binding by these NEAT domains is mediated by a conserved five amino acid aromatic motif (YYHFF in IsdH-N1, and FYHYA in IsdH-N2 and IsdB-N1) located within an α-helical loop structure at the end of the NEAT domain β-sandwich (see Figs 3A and 5); mutation of any one of these key residues severely hinders hemoglobin and/or haptoglobin binding (Pilpa et al. 2006 (Pilpa et al. , 2009 Krishna Kumar et al. 2011; Pishchany et al. 2014 ). In contrast, the C-terminal NEAT domains (IsdB-N2 and IsdH-N3) are specific for the binding of heme through the conserved YXXXY motif (see Fig. 3A ) (Pilpa et al. 2009; Gaudin et al. 2011) .
Efficient hemoglobin binding and heme extraction by IsdB and IsdH is mediated by a conserved receptor region consisting of an N-terminal hemoglobin-binding domain (IsdB-N1 and IsdH-N2) contiguous with a α-helical linker region of ∼70 amino acid residues and the C-terminal NEAT domain (IsdB-N2 and IsdH-N3) (Figs 3A and 4A) (Spirig et al. 2013; Bowden et al. 2014; Dickson et al. 2014; Zhu et al. 2014) . The linker region is comprised of an inflexible three-helix bundle, which holds the N-and C-terminal receptor domains apart by ∼40Å in an elongated dumbbell-like conformation (Fig. 4B ) (Spirig et al. 2013; Dickson et al. 2014) . In IsdH, the linker region positions IsdH-N3 directly inline with a globin heme pocket of (orange) to the αHb subunit (red) of the α:β Hb dimer. More detail on the structure can be found in Kumar et al. (2011) . IsdH-N1 residues shown to be critical for Hb binding are shown in sticks with carbon, nitrogen and oxygen colored yellow, blue and red, respectively. The K11 residue in αHb, shown critical for Hb:IsdH binding, is shown in stick with carbon and nitrogen colored green and blue, respectively. Also shown in stick format are the heme molecules bound in each of the subunits of Hb, with carbon, nitrogen and oxygen colored cyan, blue and red, respectively. the hemoglobin tetramer/heterodimer bound to IsdH-N2, and it has been proposed that this orientation facilitates rapid transfer of heme from hemoglobin to IsdH-N3 . Additionally, steric strain induced on the hemoglobin molecule by the linker region may facilitate hemoglobin dissociation and/or heme release, allowing for capture of heme by the associated heme-binding NEAT domain (Spirig et al. 2013; Bowden et al. 2014; Dickson et al. 2014) . The domain architecture of IsdB in St. lugdunensis is comparable to that of IsdB and IsdH in St. aureus, suggesting that while this protein has not been structurally or functionally characterized in St. lugdunensis, it likely fulfills the same function in this pathogen (Zapotoczna et al. 2012; Dickson et al. 2014) . While IsdH-N1 has been shown to bind both hemoglobin and haptoglobin (Dryla et al. 2003 (Dryla et al. , 2007 Pilpa et al. 2009; Visai et al. 2009; Dickson et al. 2014) , the exact function of this domain in heme-iron acquisition has yet to be determined.
Once heme is extracted, bidirectional exchange may occur between IsdB-N2 and IsdH-N3; however, all other heme transfer reactions occur in a unidirectional fashion from IsdB-N2 or IsdH-N3 to the single NEAT domain of either IsdA or IsdC (see Fig. 1 ) Muryoi et al. 2008; Zhu et al. 2008) . Self-transfer between Isd proteins may also facilitate the movement of heme through the thick cell wall (∼30 nm) (Beveridge and Matias 2006) , and physical interaction between IsdC molecules has recently been demonstrated (Grigg, Mao and Murphy 2011 ; for a model, see Abe et al. 2012) . IsdC serves as a central conduit within the Isd pathway as heme is funneled from holo-IsdA through IsdC to apo-IsdE (Sharp et al. 2007; Tiedemann, Heinrichs and Stillman 2012) . Heme transfer between Isd proteins is driven in part by affinity, where each protein in the sequential shuttle mechanism has a higher affinity for heme than the last (Moriwaki et al. 2013) , as well as through ultraweak (≥micromolar affinity), transient 'handclasp'-type protein-protein interactions (Muryoi et al. 2008; Villareal et al. 2011; Abe et al. 2012) . Handclasp transfer involves a short-lived stereospecific protein-protein complex wherein heme is passed between the conserved tyrosine residues of donor and recipient proteins (Muryoi et al. 2008; Grigg, Mao and Murphy 2011; Villareal et al. 2011; Abe et al. 2012) . Such interactions are governed by specific structural motifs, as has been demonstrated by the unambiguous lack of heme transfer from holo-IsdA to apo-IsdE (Muryoi et al. 2008; Abe et al. 2012) ; an extended β7/β8 loop region comprised of six amino acids, present in IsdC but not IsdA, is required for heme transfer between holo-IsdC and apo-IsdE (Villareal et al. 2011; Abe et al. 2012) . Indeed, chimeric expression of the IsdC β7/β8 loop region in IsdA enables heme transfer to IsdE (Abe et al. 2012) . Unlike the other cell-surface-anchored Isd proteins, IsdE does not possess a NEAT domain or conserved tyrosine residue for heme coordination. IsdE is a type III substrate-binding lipoprotein bearing a bilobate structure formed by N-and C-terminal domains bridged by a long α-helical backbone (Fig. 6) (Grigg et al. 2007b; Berntsson et al. 2010; Chu and Vogel 2011) . Heme coordination by IsdE occurs within a deep hydrophobic groove between the two domains by axial histidine and methionine residues (H229 and M78) (Fig. 6) (Grigg et al. 2007b; Pluym et al. 2007) . Notably, unlike other Isd proteins, which have been shown essential for optimal growth on heme and/or hemoglobin as a sole iron source (Torres et al. 2006; Pishchany, Dickey and Skaar 2009 , 2014 , isdE mutants lack a pronounced growth impairment on heme (Grigg et al. 2007b) , suggesting that an alternate mechanism for hemeiron acquisition likely exists in St. aureus.
The biological relevance of the St. aureus Isd system
Despite extensive characterization of the Isd system in St. aureus, and the upregulation of isd genes in human blood and serum , single isd deletion mutants have often failed to yield robust phenotypes on heme or hemoglobin as a sole iron source (Grigg et al. 2007a,b; Hurd et al. 2012; Wright and Nair 2012) . It was recently demonstrated, however, that Isd functions as a high-affinity heme-iron acquisition system at low nanomolar concentrations of heme/human hemoglobin (Pishchany et al. 2014) . Notably, this is the predicted range for the physiological concentration of free heme and hemoglobin Heme is bound between the two lobes of the protein and the iron centre is coordinated by the sulfur group of M78 and the imidazole nitrogen of H229. The heme and M78 and H229 side chains are shown in stick format, with carbon, nitrogen, oxygen and sulfur colored yellow, blue, red and dark yellow, respectively. The iron in heme is shown as a red sphere. (Dryla et al. 2003; Sassa 2004) . At supraphysiological concentrations of heme-iron, exceeding ∼50 nM, the utility of the Isd system appears to be masked by an as yet unidentified low-affinity heme-iron acquisition system or, alternatively, by receptor-independent insertion of the planar heme molecule into the cell membrane. Indeed, the biological relevance of the Isd system is highlighted by the fact that single deletion mutants of isdA, isdB, isdC, isdG, isdH or isdI alone are sufficient to attenuate staphylococcal virulence and/or burden in murine models of infection (Torres et al. 2006; Reniere and Skaar 2008; Visai et al. 2009; Pishchany et al. 2014) . Moreover, several of these proteins are required for the formation of staphylococcal abscesses, which facilitate persistence and further dissemination within the host (Cheng et al. 2009 ). Further, individuals suffering from staphylococcal infections often express anti-IsdA, IsdB and IsdH antibodies (Clarke et al. 2006; Zorman et al. 2013) , which has prompted efforts in utilizing cell-surface-associated heme-iron acquisition proteins such as IsdA and IsdB as potential vaccine antigens (Kuklin et al. 2006; Stranger-Jones, Bae and Schneewind 2006; Kim et al. 2010) .
Staphylococcus lugdunensis
Commonly found as a normal constituent of the skin microflora, St. lugdunensis is a coagulase-negative staphylococcus (CoNS) that has gained notoriety for its propensity to cause atypically severe disease relative to other CoNS (Rosenstein and Götz 2013) . Staphylococcus lugdunensis most frequently presents as infections of the SSTIs (55.4%); however, infections of the blood and indwelling medical devices account for a notable 14.7% of reported cases (Herchline and Ayers 1991) . Of particular concern, St. lugdunensis-associated endocarditis possesses a strikingly high mortality rate of up to 50% (Anguera et al. 2005) . Efforts to identify the molecular determinants of St. lugdunensis virulence are as of yet in their infancy, but have been furthered in recent years by the release of genome sequences for two St. lugdunensis strains, N920143 and HKU09-01 (Tse et al. 2010; Heilbronner et al. 2011 ).
Unique amongst the CoNS, St. lugdunensis encodes an Isd system comparable to St. aureus and notably, as opposed to the locus in N920143, it is tandemly duplicated in HKU09-01 (Tse et al. 2010; Haley et al. 2011; Heilbronner et al. 2011; Zapotoczna et al. 2012; Brozyna, Sheldon and Heinrichs 2014) . Similar to St. aureus, St. lugdunensis encodes four NEAT domain-containing proteins, including orthologs to the hemoglobin receptor IsdB, and the heme-binding protein, IsdC, the former of which is capable of transferring heme directly to the latter (Zapotoczna et al. 2012) . However, notable differences do exist between the Isd loci of the staphylococci, as St. lugdunensis does not encode for IsdA or IsdH. Instead, the opportunistic pathogen encodes two IsdAlike proteins, IsdK and IsdJ, bearing one and two NEAT domains, respectively. Despite bearing C-terminal sortase recognition signals, both IsdJ and IsdK are found to be constrained to the membrane and to a lesser extent, the supernatant fraction, suggesting that either the sortases of St. lugdunensis are defective in anchoring these proteins or that they may be secreted into the extracellular milieu Zapotoczna et al. 2012) . Further analysis of the supernatant fraction of St. lugdunensis grown under iron restriction revealed the presence of IsdB, in addition to the aforementioned IsdJ and IsdK, and that all three proteins were smaller in size than their respective cell-surface-associated counterparts. These findings support the notion that IsdB, IsdK and IsdJ may be subject to proteolysis which releases them from the cell surface (Zapotoczna et al. 2012) .
Although neither IsdJ nor IsdK is capable of binding hemoglobin, it has been suggested that they may acquire heme from the external environment, or from secreted IsdB, in a manner analogous to the hemophores of B. anthracis; however, this is a notion requiring further investigation (Zapotoczna et al. 2012) . Notably, IsdB of St. lugdunensis binds both hemoglobin and hemoglobin-haptoglobin complexes, with a proclivity for human over mouse hemoglobin (K d of 23 nM versus ∼177 μM, respectively) (Zapotoczna et al. 2012) . The preference of St. lugdunensis for human hemoglobin may be reflective of its exclusivity as a human pathogen, and highlights the challenges in developing a suitable model for assessing its in vivo survival and virulence (Pishchany et al. 2010; Zapotoczna et al. 2012) . Regardless, the Isd system of St. lugdunensis effectively facilitates the use of both heme and hemoglobin as iron sources in vitro, and indeed these may represent the preferred iron sources of this pathogen, given its inability to synthesize endogenous siderophores (Zapotoczna et al. 2012; Brozyna, Sheldon and Heinrichs 2014) . Lastly, although lacking IsdI, St. lugdunensis encodes a functional IsdG-type heme oxygenase, which degrades heme to staphylobilin with the release of iron .
Streptococcus pyogenes
The streptococci are a diverse genus of Gram-positive Firmicutes, which exist both as harmless commensal organisms, as well as formidable human and zoonotic pathogens. Heme-iron acquisition in the streptococci has best been characterized in the group A streptococcus (GAS), S. pyogenes, a β-hemolytic, extracellular human pathogen capable of causing both noninvasive infections such as pharyngitis (strep throat), scarlet fever and impetigo, and invasive infections such as necrotizing fasciitis, bacteremia and streptococcal toxic shock syndrome (Cunningham 2000 (Cunningham , 2008 . GAS utilizes host heme-iron sources, including hemoglobin, myoglobin and hemoglobin-haptoglobin complexes, but there is no evidence for its use of iron-loaded glycoproteins transferrin and lactoferrin as growth-promoting agents, owing to a lack of endogenous siderophore production (Eichenbaum et al. 1996) . As such, heme is likely the principal iron source for GAS in vivo, and its acquisition is mediated by a heme shuttle mechanism analogous to the Isd system of the staphylococci.
To date, the only pathway described for the extraction and transport of heme-iron from host hemoproteins in GAS is transcribed from a single, highly conserved, iron-regulated, 10-gene operon, referred to as Sia (for streptococcal iron acquisition) (Bates et al. 2003) . Many streptococcal heme acquisition proteins parallel those found in the staphylococci in terms of both structure and function. The first gene of the operon encodes the streptococcal hemoprotein receptor, Shr, so termed for its capacity to bind hemoglobin, myoglobin, heme-albumin and hemoglobin-haptoglobin complexes (Bates et al. 2003) . While displaying a more diverse range of potential substrates, Shr can be considered functionally analogous to IsdB and IsdH in St. aureus in that it facilitates heme-iron acquisition from host hemoproteins.
Shr is a large (145 kDa), hydrophilic protein and although it possesses two NEAT domains, it lacks significant overall sequence homology to, or commonality in domain architecture with other known heme acquisition proteins (Bates et al. 2003; Ouattara et al. 2010) . Shr instead represents a novel composite NEAT domain-containing protein, consisting of a unique Nterminal domain (NTD) and two NEAT domains (Shr-N1 and Shr-N2), the latter of which are separated by a central leucine rich-repeat (LRR) region (Fig. 3B) (Fisher et al. 2008; Ouattara et al. 2010) . While the function of the LRR region remains unknown, it is also found in the heme-binding proteins IlsA and HaI of B. cereus and B. anthracis, respectively (Carlson et al. 2009; Daou et al. 2009; Segond et al. 2014) , suggesting that it may have an as yet uncharacterized role in heme-iron acquisition. Limited orthologs of Shr are found in other pyogenic streptococci and Clostridium novyi (a causative agent of gas gangrene), where several other unusual or undefined features further delineate these heme-binding proteins from other NEAT domaincontaining proteins. Uncharacterized elements of Shr include two domains of unknown function (DUF1533) located adjacent to the N-terminal leader peptide, an EF-hand motif between Shr-N1 and the LRR region (Ouattara et al. 2010) , and a short hydrophobic tail purportedly responsible for anchoring the protein to the cell membrane in lieu of cell wall anchorage by a sortase enzyme (Fisher et al. 2008) . The complex domain architecture of Shr undoubtedly contributes to its disparate means of hemoprotein/heme coordination and multifaceted role as a virulence factor.
While the function of many of the aforementioned domains and motifs have yet to be investigated, it is noteworthy that hemoprotein binding by Shr is mediated by an unspecified region in the NTD, and not by the NEAT domains Shr-N1 or Shr-N2 (Ouattara et al. 2010) . Indeed, Shr homologs truncated within Shr-N1 (leaving NTD intact) still retain the ability to bind hemoglobin, as seen in the equine respiratory pathogen Streptococcus equi sub. spp. equi (S. equi) (Timoney 2004; Meehan et al. 2010) . Consistent with their inability to bind hemoglobin, Shr-N1 and Shr-N2 both lack the aromatic hemoglobin-binding motif found in IsdB and IsdH (Pilpa et al. 2006; Ouattara et al. 2010; Krishna Kumar et al. 2011; Bowden et al. 2014; Dickson et al. 2014; (also see Fig. 3B ), suggesting that GAS employs a novel means of hemoprotein coordination. Similarly, while both Shr-N1 and Shr-N2 are capable of binding extracted heme, the axial ligands involved in this activity have yet to be defined and both domains are missing the paradigmatic iron-coordinating tyrosine found in staphylococcal heme-binding NEAT domains (e.g. Y166 of IsdA) (Ouattara et al. 2010; Grigg, Mao and Murphy 2011) .
In addition to its function as a hemoprotein/heme-receptor, Shr behaves as a microbial surface component recognizing adhesive matrix molecules (MSCRAMM), capable of mediating bacterial attachment to host cells through binding of extracellular matrix components (ECM) such as laminin (Fisher et al. 2008; Ouattara et al. 2010; Dahesh, Nizet and Cole 2012) . Adherence to ECM components is allegedly mediated for the most part by Shr-N2, although the mechanism of binding has not been elucidated (Ouattara et al. 2010) . Unsurprisingly, given its potential for multifaceted interaction within the host, Shr has been shown essential for maximal virulence, including in a zebrafish model of necrotizing fasciitis, and in murine models of skin and systemic infection (Fisher et al. 2008; Dahesh, Nizet and Cole 2012) . Additionally, Shr promotes survival in whole human blood, likely due to its role in heme-iron acquisition (Dahesh, Nizet and Cole 2012) . Indeed, Shr is expressed in the host during infection, is highly immunogenic and, accordingly, has been investigated as a potential vaccine target (Fisher et al. 2008; Huang et al. 2011; Dahesh, Nizet and Cole 2012) .
Shr also plays a multifunctional role in maintaining homeostatic heme-iron concentrations within the cell, by controlling the rate at which exogenous heme is acquired. Analysis of the kinetics of heme transfer by Shr-N1 and Shr-N2 revealed that the two domains exhibit fundamental differences in their heme-transfer capabilities, where Shr-N1 is capable of transferring heme slowly to Shr-N2, and rapidly to a second streptococcal hemeassociated cell-surface protein, Shp (Lei et al. 2002; Ouattara et al. 2013) . In contrast, Shr-N2 is not capable of transferring heme to Shp; however, it is capable of transferring heme back to Shr-N1, and it has been suggested that Shr-N2 may effectively serve to sequester heme that is present in excess (Ouattara et al. 2013) , as has been similarly been proposed for the hemophore IsdX2 of B. anthracis (Fabian et al. 2009 ). When heme is limiting, Shr-N2 purportedly transfers heme back to Shr-N1, which subsequently transports it to the IsdC analog, Shp.
The amino acid homology between Shp and the NEAT domains of is comparable to the homology between these two proteins (19%), suggesting that Shp is likely a divergent member of the NEAT family. As with the NEAT domains, the heme-binding domain of Shp bears an immunoglobin-like β-sandwich fold, comprised of eight β-strands apportioned between two antiparallel β-sheets of three and four β-strands, respectively (Fig. 2) . The two β-sheets are connected by the eighth β-strand, between which forms the substrate-binding pocket (Aranda et al. 2007) . In contrast to canonical NEAT domains, low-spin heme is bound in a hexacoordinate fashion by the sulfur atoms of two axial methionine residues situated on a small α-helix (M66) and between the seventh and eighth β-strands (M153) (Fig. 2) (Aranda et al. 2007) . Like IsdC, Shp serves as a central conduit within the cell wall, transferring heme to HtsA, the substrate-binding lipoprotein component of the ABC-type heme transporter of group A streptococcus, HtsABC (also known as SiaABC) (Bates et al. 2003; Lei et al. 2003) .
The htsABC operon is located on the genome downstream of shp. While HtsA is a membrane-anchored heme receptor, HtsB is a membrane permease and HtsC is an ATPase (Bates et al. 2003; Lei et al. 2003) . Like staphylococcal IsdEF, streptococcal HtsABC functions in the translocation of heme across the cell membrane. HtsA shares 39% amino acid sequence similarity with IsdE (Liu and Lei 2005) , and similarly coordinates heme through axial histidine (H229) and methionine residues (M79), with H229 being essential for binding (Sook et al. 2008; Ran et al. 2010) . The affinity driven transfer of heme from Shp to HtsA is mediated by the formation of an activated holo-Shp:apo-HtsA complex (Liu and Lei 2005; Nygaard et al. 2006) , where the axial residues of holo-Shp (Met66 and Met153) displace those of apo-HtsA (His229 and Met79) in a single kinetic phase (Nygaard et al. 2006; Ran et al. 2013) . Together these findings support a model whereby GAS Shr binds hemoglobin at the cell surface via an NTD and transfers extracted heme to Shr-N1. In the presence of excess heme, Shr-N1 may transfer heme to Shr-N2 for sequestration, which is transferred back to Shr-N1 when iron is limiting. Heme is then conveyed via Shp from Shr-N1 to the heme-specific substratebinding lipoprotein, HtsA, whereupon it is transported into the cytoplasm via HtsBC (Ouattara et al. 2013) . The mechanism(s) by which heme is degraded in GAS has not yet been elucidated, nor can one easily be inferred since GAS lacks a clear ortholog of recognized heme oxygenases.
Bacillus anthracis
Bacillus anthracis, a Gram-positive, endospore-forming, facultative anaerobe, is the etiological agent of anthrax and a potential bioweapon (Mock and Fouet 2001; Inglesby et al. 2002) . The dynamic life cycle of the pathogen, including highly resilient spores and vegetative cells, as well as both intracellular and extracellular replication, necessitates an ability to exploit multiple iron sources within the host (for a review, see Honsa and Maresso 2011) . Infectious B. anthracis spores that are inhaled, ingested or introduced to the host through cutaneous penetration are rapidly phagocytosed and disseminated to regional lymph nodes by macrophages (Shetron-Rama et al. 2010) . Germination of B. anthracis spores occurs within the phagosome, and the resulting vegetative cells proliferate before lysing the macrophage and disseminating broadly within the host via the bloodstream (Guidi-Rontani et al. 1999; Dixon et al. 2000; Klichko et al. 2003; Shannon et al. 2003) . The secretion of siderophores has been shown essential to the intracellular survival of B. anthracis (Cendrowski, MacArthur and Hanna 2004) , where hemeiron is limited. Upon escape from the macrophage, B. anthracis may then utilize an array of heme-iron acquisition proteins to facilitate its rapid and systemic proliferation (Honsa and Maresso 2011) .
Bacillus anthracis encodes an Isd heme-uptake system with characteristics that are similar to the staphylococcal Isd system, but at the same time possesses aspects that are quite distinct (Maresso, Chapa and Schneewind 2006; Gat et al. 2008) . While encoding homologs to IsdC and SrtB, B. anthracis lacks other cell-wall-associated heme-binding proteins such as IsdA, IsdB and IsdH (Maresso, Chapa and Schneewind 2006) . Alternatively, B. anthracis encodes two proteins, IsdX1 (formerly known as IsdJ) and IsdX2 (formerly known as IsdK), which contain one and five NEAT domains, respectively (Fig. 3C ). Interestingly, both IsdX1 and IsdX2 lack C-terminally localized membrane-spanning or cell-wall-anchoring motifs (Gat et al. 2008; Maresso, Garufi and Schneewind 2008) , and are instead secreted into the extracellular milieu where they function as heme-scavenging 'hemophores' (Gat et al. 2008; Maresso, Garufi and Schneewind 2008) . Bacterial hemophores have best been characterized in Gram-negative bacteria, with the paradigmatic hemophore system being HasA and its outer membrane receptor HasR from Serratia marcescens (Izadi-Pruneyre et al. 2006; Cescau et al. 2007 ). IsdX1 and IsdX2 represent the first identification of hemophores amongst Gram-positive bacteria and, notably, whilst the two encoding genes are conserved within the Bacillus cereus group (including B. anthracis, B. cereus and B. thuringiensis), they are absent from other Gram-positive pathogens such as Staphylococcus spp., Clostridium spp. and Streptococcus spp. (Maresso, Garufi and Schneewind 2008) . The expression of hemophores by B. anthracis, in particular, may be a reflection of the complexity of its cell surface, which possesses both an antiphagocytic protein capsule and, like other bacilli, a crystalline protein array referred to as the S (surface)-layer (Mesnage et al. 2000; Fouet and Mesnage 2002; Drysdale et al. 2005) . The utilization of both extracellular and cell-surface-associated hemebinding proteins may help facilitate the passage of heme across the fortified B. anthracis cell envelope.
Unlike HasA, which utilizes a diverse range of heme-iron sources (Cescau et al. 2007) , B. anthracis hemophores possess limited substrate specificity and are capable of extracting heme from host hemoglobin, but not myoglobin or hemoglobinhaptoglobin complexes (Gat et al. 2008; Maresso, Garufi and Schneewind 2008) . Further, the individual NEAT domains of IsdX1 (IsdX1-N1) and IsdX2 (IsdX2-N1 to -N5) possess distinct functionalities; IsdX1-N, and IsdX2-N1, -N3, -N4 and -N5 all bind heme (the latter with highest affinity) using the conserved YXXXY heme-binding motif (see Fig. 3C ), IsdX1-N, IsdX2-N1 and -N5 extract heme from hemoglobin, and IsdX1-N, IsdX2-N1, -N3 and -N4 are all capable of transferring heme to apo-IsdC (Maresso, Garufi and Schneewind 2008; Fabian et al. 2009; Honsa et al. , 2013 . Notably, IsdX2-N2 displays a perturbation in the heme-binding motif, where histidine is found in place of the second tyrosine; this domain interacts with hemoglobin, but similar to IsdB-N1, IsdH-N1 and IsdH-N2 of St. aureus, is not directly involved in heme binding . While an exact mechanism for heme extraction by IsdX1-N, IsdX2-N1 and IsdX2-N5 has not been defined, a glutamine residue (Q29) within the 3 10 -helix of IsdX2-N1 and IsdX2-N5 has been shown essential to this activity (Ekworomadu et al. 2012; Honsa et al. 2013) . A role for IsdX2-N2 functioning synergistically with other IsdX2 NEAT domains to promote heme extraction, however, has not yet been discounted. Further investigation is required to fully elucidate the means by which IsdX1 and IsdX2 promote heme extraction from hemoglobin.
As with St. aureus, the transfer of heme between Isd proteins in B. anthracis is facilitated by transient protein-protein interactions, where in addition to transferring extracted heme unidirectionally to apo-IsdC, holo-IsdX1 is able to transfer heme to apo-IsdX2 (Fabian et al. 2009 ). While the transfer of heme between two secreted heme-binding proteins seems counterintuitive, it has been suggested that the multiple NEAT domains of IsdX2 may function to sequester heme in an effort to control the rate of heme uptake under varying extracellular concentrations, effectively serving as a 'heme sponge' (Fabian et al. 2009; . Alternatively, IsdX2 may function in a manner analogous to IsdA in St. aureus, given that a fraction of the hemophore (∼20%) is cell-wall-associated (Maresso, Garufi and Schneewind 2008; Fabian et al. 2009) , and may also serve to relay heme to IsdC. Binding and transport of heme at the cell surface may be further facilitated by the NEAT domain-containing B. anthracis S-layer homology protein K, BslK (Tarlovsky et al. 2010) . BslK is covalently linked to the external surface of the cell by its S-layer homology (SLH) domain and, like the hemophores, can rapidly transfer heme to apo-IsdC through direct interaction (Tarlovsky et al. 2010) . The currently proposed model for B. anthracis heme-iron acquisition suggests a dynamic system where both Isd and nonIsd heme-binding proteins can facilitate transfer to IsdC. In this model, extracellular vegetative cells of B. anthracis secrete IsdX1 and IsdX2 to scavenge heme from host hemoglobin. Extracted heme is transferred from IsdX1 to IsdC within the cell wall, or sequestered by IsdX2, controlling the rate at which it is subsequently transferred to IsdC (Fabian et al. 2009; . Alternatively, the S-layer-associated BslK may transfer heme directly to IsdC, from which heme is transferred to a putative IsdEF homolog (Honsa and Maresso 2011) . Like St. lugdunensis, B. anthracis encodes a single IsdG-type hemedegrading oxygenase for the liberation of iron from heme subsequent to its transport into the cytoplasm (Skaar, Gaspar and Schneewind 2006) .
As suggested for St. aureus and L. monocytogenes, alternate non-Isd heme-iron acquisition systems likely exist in most, if not all, Gram-positive pathogens given the failure of Isd locus deletions to fully abrogate growth of these organisms on heme as a sole iron source. For example, isdC or bslK did not abolish heme or hemoglobin utilization by B. anthracis (Maresso, Chapa and Schneewind 2006; Gat et al. 2008; Balderas et al. 2012) , nor did a triple isdC isdX1 isdX2 deletion impair its virulence (Gat et al. 2008) . Inquiry into alternate means of heme uptake in this pathogen identified an additional iron-regulated, NEAT domain and LRR-containing protein, that also contributes to virulence in a mouse model of inhalational anthrax (Carlson et al. 2009 ). Further characterization of this protein, Hal (for heme-acquisition leucine-rich repeat protein), revealed that it is capable of extracting heme from hemoglobin for uptake by B. anthracis through an as yet unidentified transporter, and is potentially more important than Isd or BslK for growth on heme and hemoglobin (Balderas et al. 2012) . While the NEAT domain of Hal is sufficient for liberation of heme from hemoglobin (Balderas et al. 2012) , investigations into the function of LRRs in iron acquisition are ongoing. Additionally, another NEAT, LRR, SLH domaincontaining protein identified in B. cereus (IlsA; iron-regulated leucine-rich surface protein A) was recently shown capable of binding and promoting iron uptake from heme, hemoglobin and ferritin (Daou et al. 2009; Segond et al. 2014) . The plethora of heme-iron acquisition systems in the B. cereus group suggests either functional redundancy in these proteins, which may enhance overall heme uptake, or the potential for differential regulation between the systems, allowing for multifaceted control over heme acquisition during the course of infection (Balderas et al. 2012) .
Listeria monocytogenes
Listeria monocytogenes is a ubiquitous Gram-positive Firmicute, and the causative agent of listeriosis, a rare but serious foodborne illness. The most frequent clinical presentations of listeriosis include maternofetal or neonatal listeriosis, septicemia and meningoencephalitis, where the case fatality rate approaches 30% (Swaminathan and Gerner-Smidt 2007) . Listeria monocytogenes is a facultative intracellular bacterium, capable of inducing its own internalization by non-phagocytic cells and surviving inside professional phagocytes, and expresses a vast array of virulence factors to facilitate this life cycle (Camejo et al. 2011; Carvalho, Sousa and Cabanes 2014) . While decades of research have helped elucidate the means by which L. monocytogenes survives and proliferates within the host, investigation of iron acquisition mechanisms in this organism is still somewhat limited.
Listeria monocytogenes expresses one putative hemophore, Hbp1 (Lmo2186), and one bona fide hemophore, Hbp2 (Lmo2185) (Hbp: hemin-binding protein), containing one (in Hbp1; Hbp1-N1) and three (in Hbp2; Hbp2-N1 to -N3) dual-function NEAT domains (Xiao et al. 2011; Malmirchegini et al. 2014) (Fig. 3D) .
Each of the L. monocytogenes NEAT domains are capable of binding heme, where Hbp1-N, and the Hbp2-N1 and -N3 are also capable of binding hemoglobin, all with affinity in the nanomolar range (Malmirchegini et al. 2014) . The ability of the aforementioned NEAT domains to function in both heme extraction and transfer is analogous to NEAT domains of IsdX1 and IsdX2 of B. anthracis, but contrary to the NEAT domains of St. aureus IsdH and IsdB, where in the latter these domains act synergistically to release heme from hemoglobin.
Hbp1 and Hbp2 are encoded from an iron-regulated locus comparable to the Isd locus of St. aureus. To date, aside from these two aforementioned proteins, the rest of the genes in the locus remain uncharacterized. Like IsdX2 of B. anthracis, Hbp2 is both secreted and cell-wall-associated, suggesting that it may function both as a hemophore and as a cell surface receptor for heme and hemoglobin (Maresso, Garufi and Schneewind 2008; Fabian et al. 2009; Malmirchegini et al. 2014) . This model is supported both by the rapid exchange of heme observed between Hbp2 NEAT domains and by the inability of an hbp2 mutant to acquire heme from purified holo-Hbp2 (Xiao et al. 2011; Malmirchegini et al. 2014) . Characterization of Hbp2-N2 revealed a novel mechanism for heme binding by NEAT domains, whereas most other heme-binding NEAT domains characterized to date employ conserved tyrosines in the YXXXY motif (streptococcal Shp and Shr being other notable exceptions), Hbp2-N2 coordinates heme using a non-canonical tyrosine located on the β7 strand instead of the β8 strand (Malmirchegini et al. 2014) . Additionally, unlike IsdA-N and IsdH-N3 of St. aureus and IsdX1-N of B. anthracis, Hbp2-N2 undergoes a major conformational change upon heme binding, due in part to a lack of stabilizing residues found in the β7/β8 loop, which results in the adoption of a relatively flexible preformed heme-binding pocket (Malmirchegini et al. 2014) . Although the mechanism of heme transfer in L. monocytogenes has not yet been determined, it is predicted to occur between coordinated tyrosine residues through transient protein-protein interactions, as with other Isd proteins. Further, while Hbp1 is capable of binding both heme and hemoglobin, its biological function remains unclear. Lastly, as with the Isd systems of St. aureus and St. lugdunensis, it is noteworthy that Hbp1 and Hbp2 have been implicated in heme acquisition only when heme-iron concentrations are below 50 nM. Heme-iron present in micromolar concentrations may obviate the need for high-affinity acquisition systems, and it is proposed that under these circumstances, L. monocytogenes employs a putative low-affinity heme/hemoglobinuptake ABC-transporter, HupDGC (Jin et al. 2006; Xiao et al. 2011; Klebba et al. 2012) .
NON-ISD HEME ACQUISITION MECHANISMS
Corynebacterium diphtheriae
Corynebacterium diphtheriae, a member of the Actinomycetes, is a non-motile, non-spore forming, facultative anaerobe with a pleiomorphic cell shape and a high G+C content (∼53%) relative to the Firmicutes (Cerdeño-Tárraga et al. 2003; Trost et al. 2012) . Corynebacterium diphtheriae is the causative agent of diphtheria, a severe human respiratory disease characterized by pharyngitis and pseudomembranous inflammation formed on one or both tonsils, the latter of which may disseminate resulting in complete airway obstruction and death (Hadfield et al. 2000) . Further, like other pathogens, iron serves as an important environmental cue for C. diphtheriae, promoting the expression of virulence factors that contribute to its survival and pathogenicity within the iron-restricted host. The primary virulence determinant of C. diphtheriae is bacteriophage-borne diphtheria toxin (DT), an exotoxin capable of gaining entry to host cells and impeding protein synthesis. Dissemination of DT beyond the infection foci may result in systemic toxic effects, particularly within the myocardium and peripheral nervous system (Bell and Eisenberg 1996; Hadfield et al. 2000) . The DT-encoding gene, tox, is negatively regulated by iron and the global transcriptional regulator, DtxR (for a comprehensive review, see Holmes 2000) . Despite extensive characterization of tox regulation by DtxR and iron, comparatively little is known about the remainder of the iron regulon of C. diphtheriae, which may include in excess of 20 DtxR-regulated loci (Cerdeño-Tárraga et al. 2003; Kunkle and Schmitt 2003) . To date, C. diphtheriae is known to encode a DtxR-regulated siderophore synthesis and high-affinity transport system (ciuABCDEFG), three loci involved in non-Isd heme-iron acquisition, and a canonical heme monooxygenase (hmuO).
The first heme-iron acquisition system to be identified and characterized in Gram-positive bacteria was the hemin-uptake locus, hmu, of C. diphtheriae (Drazek, Hammack and Schmitt 2000) . Initially isolated in a screen for heme-and hemoglobinuptake-deficient mutants of C. diphtheriae and its close relative C. ulcerans, the locus contains genes bearing homology to hemespecific ABC transporters of Gram-negative pathogens, specifically hmuTUV of Yersinia pestis (Hornung, Jones and Perry 1996; Thompson, Jones and Perry 1999; Drazek, Hammack and Schmitt 2000) . In C. diphtheriae, the six-gene locus encodes a membraneassociated heme/hemoglobin-binding protein (HmuT), as well as a putative heme-specific permease (HmuU), and predicted ATPase (HmuV) (Drazek, Hammack and Schmitt 2000) . A subsequent screen for DtxR-regulated loci revealed three additional genes associated with the hmuTUV locus (htaABC), encoding the heme transport-associated proteins HtaA (OrfX), HtaB and HtaC, the latter two of which are transcribed from DtxR promoters independent of hmuTUV (Kunkle and Schmitt 2003; Allen and Schmitt 2009 ).
Investigation into the localization of the Hmu-Hta proteins revealed that in contrast to the Isd proteins, which employ sortases for membrane anchorage of cell surface proteins, HtaA and HtaB possess a C-terminal transmembrane region for covalent attachment to the cell membrane, despite also possessing N-terminal leader sequences for secretion Schmitt 2009, 2011) . Notably, while HmuT and HtaB are primarily localized to the cytoplasmic membrane, HtaA is released into the extracellular milieu, and to a lesser extent is associated with the cell membrane, during growth in iron-restricted rich media (Allen and Schmitt 2009 ). While the role that HtaA localization plays in heme-iron acquisition has not been determined, the inability of heme-loaded HtaA to support growth of an htaA mutant suggests a system analogous to Hbp2 of L. monocytogenes, where the protein serves both as a hemophore and as a heme receptor (Maresso, Garufi and Schneewind 2008; Allen and Schmitt 2009; Fabian et al. 2009; Malmirchegini et al. 2014) ; however, this notion requires further investigation.
The binding of heme and hemoproteins to HtaA and HtaB occurs through a novel and unique conserved region (CR) of approximately 150 amino acids, distinct from the heme-binding NEAT domains of Staphylococcus spp., Streptococcus spp. and Bacillus spp. (Allen and Schmitt 2011) . HtaA bears two such CR domains, CR1 and CR2, capable of binding heme, hemoglobin, myoglobin, human serum albumin and hemoglobin-haptoglobin complexes, with CR2 serving as the predominant heme/hemoprotein-binding domain (Allen and Schmitt 2014) . In contrast, HtaB contains a single CR with an affinity only for heme, suggesting that this protein likely serves as an intermediary in the transfer of heme from the cell surface to the cell membrane (Allen and Schmitt 2009 , 2014 . Similar to other heme-binding proteins, two conserved tyrosines, as well as a histidine residue, within the CR motif have been implicated in heme binding (Allen and Schmitt 2011) , although the exact mechanism of binding and heme extraction has not been investigated. Additionally, while apo-HtaA has been shown capable of acquiring heme from host hemoproteins, and apo-HtaB in receiving heme from holo-HtaA, binding of these proteins has not been demonstrated Schmitt 2011, 2014) . It is possible that heme transfer within the Hmu-Hta system occurs through natural diffusion; however, it is more likely that as with Isd, the interactions between the cell-surface-associated proteins are transient and weak and were not readily detected by the methodology employed (Allen and Schmitt 2011) . While the Hmu-Hta system of C. diphtheriae presents novel aspects of heme acquisition in Gram-positive pathogens, chiefly the means by which the proteins are anchored to the cell envelope and the unique domain required to bind heme, the shuttling of heme through the cell envelope occurs ostensibly in a manner analogous to Isd; HtaA acquires heme from host hemoproteins and transfers heme either directly to HmuT or indirectly to HmuT through HtaB. By way of the heme ABC transporter HmuTUV, extracted heme is transported into the cytosol and iron is released through degradation by the canonical heme oxygenase, HmuO (Schmitt 1997a,b; Schmitt 2009, 2011) .
While HmuT, HtaA and HtaB have all been shown to bind heme and/or hemoproteins, and hmuTUV and htaA are required for maximal growth on low concentrations of these iron sources in deferrated media (Drazek, Hammack and Schmitt 2000; Schmitt 2009, 2011) , the concerted activity of the Hmu/Hta proteins in the extraction and transport of heme has not been conclusively determined. Further, individual gene deletions, or deletion of the complete hmu-hta locus, reduces but does not abolish growth on heme-iron as a sole iron source, suggesting that alternate means of heme uptake likely exist in C. diphtheriae (Drazek, Hammack and Schmitt 2000; Schmitt and Drazek 2001; Allen and Schmitt 2009 ). An effort to identify additional corynebacterial heme transport-associated proteins revisited the heme-uptake capabilities of a previously identified two-gene DtxR-regulated operon, chtAB, where chtA and chtB are homologs of htaA and htaB, respectively (Kunkle and Schmitt 2003; Allen, Burgos and Schmitt 2013 ). Interestingly, considerable diversity exists in the iron-uptake systems present in sequenced C. diphtheriae strains, where chtAB is found both on a composite transposon within epidemic clones from the 1990s outbreak of diphtheria in the former Soviet Union, and also in the core genome of other clinical C. diphtheriae isolates, but is absent from some commonly employed laboratory strains (Kunkle and Schmitt 2003; Trost et al. 2012; Allen, Burgos and Schmitt 2013) . Similarly, a second operon, cirA chtC, was identified based on sequence similarity to chtAB, and was also found in many of the aforementioned clinical isolates (Allen, Burgos and Schmitt 2013) . The significance of chtAB and cirA chtC to the in vivo survival and virulence of C. diphtheriae has not been elucidated.
Characterization of ChtA, ChtB, ChtC and CirA revealed that, with the exception of CirA, each protein bears a single CR domain, and is capable of binding heme and hemoglobin (Allen, Burgos and Schmitt 2013) . Ongoing research into the roles of ChtA, ChtB and ChtC in C. diphtheriae heme-iron acquisition suggests complex and redundant interplay between these proteins and the previously characterized HtaA and HtaB. Like HtaA, ChtA and ChtC are additionally capable of binding hemoglobinhaptoglobin complexes (Allen and Schmitt 2014) , whereas ChtB is not capable of binding this substrate and instead appears to be functionally redundant with HtaB (Allen, Burgos and Schmitt 2013) . Direct interaction between ChtB and HtaA in mediating heme transport through the cell envelope, however, has not yet been demonstrated and further investigation is required. In contrast, chtA and chtC do not appear to be involved in the acquisition of free heme, as deletion of these two genes in conjunction with htaA failed to impair heme utilization relative to an htaA mutant alone (Allen, Burgos and Schmitt 2013) . Instead, and consistent with their binding capabilities, HtaA, ChtA and ChtC mediate the use of hemoglobin-haptoglobin as a sole iron source, where HtaA works in concert with either of the functionally redundant ChtA or ChtC proteins to facilitate this activity. It has recently been proposed that ChtA or ChtC interact with HtaA through an unknown mechanism to bind hemoglobinhaptoglobin at the cell surface and facilitate the release of heme which is captured by HtaA and subsequently transferred to HtaB (or maybe ChtB) prior to transport through the membrane by HmuTUV (Schmitt 2014) . Notably, while the use of hemoglobinhaptoglobin complexes as an iron source is widespread amongst C. diphtheriae isolates, strains lacking intact chtA, chtC and htaA genes are still capable of utilizing this hemoprotein as an iron source, suggesting that an alternate mechanism for the acquisition of heme-iron from hemoglobin-haptoglobin likely exists (Schmitt 2014) . Together these findings advocate for further efforts in explicating the interactions between hmu-hta, chtAB and chtC, and in identifying additional heme acquisition pathways in C. diphtheriae given that disruption in all known heme-ironuptake loci has, to date, failed to completely abrogate heme-iron utilization in this bacterium.
IRON RELEASE: MECHANISMS OF HEME DEGRADATION
Internalized heme faces two potential outcomes: (i) direct incorporation into bacterial hemoproteins or (ii) cytosolic destruction of the heme-iron complex, releasing iron for use as a nutrient. Liberation of iron from the heme necessitates hemedegrading enzymes and, to this effect, eukaryotic organisms employ heme oxygenases (HOs) that convert heme to biliverdin and iron with the release of carbon monoxide (CO) (Wilks 2002) . Similarly, the Gram-positive pathogen C. diphtheriae and Gramnegative pathogens Neisseria meningitidis and Pseudomonas aeruginosa employ canonical HOs that are structurally and mechanistically comparable to their eukaryotic counterparts to facilitate iron release from heme (Wilks and Schmitt 1998; Zhu, Wilks and Stojiljkovic 2000; Ratliff et al. 2001) . Research within the last decade has revealed a separate class of heme-degrading enzymes that are distinct from traditional HOs, the IsdG family of heme oxygenase proteins, first recognized in St. aureus Schneewind 2004, 2006) . These noncanonical HOs degrade heme to novel chromophores termed staphylobilins, with the release of iron and formaldehyde ( Fig.  7) (Reniere et al. 2010; Matsui et al. 2013) . The distinct degradation products of IsdG-type HOs reflect different metabolic requirements of the bacteria in which they are employed, as well as unique structural and mechanistic properties of these heme-degrading proteins (reviewed in Wilks and Ikeda-Saito 2014) .
Canonical HOs
The first bacterial heme oxygenase to be characterized was HmuO of C. diphtheriae, initially identified in a screen for heme and hemoglobin utilization-deficient mutants of C. ulcerans and C. diphtheriae (Schmitt 1997b) . HmuO is a 24 kDa soluble protein bearing extensive homology to the 33 kDa human heme oxygenase enzyme HO-1 (Schmitt 1997b) . Like its membranebound eukaryotic counterparts, HmuO facilitates degradation of heme to biliverdin, iron and CO (Wilks and Schmitt 1998) . Monomeric HmuO binds heme in a 1:1 ratio with a K d (2.5 ± 1 μM) comparable to HO-1 (0.84 ± 0.2 μM) (Wilks et al. 1996; Wilks and Schmitt 1998) , and as with other traditional HOs, adopts an α-helical structural fold where heme is secured between the proximal and distal helices (see Fig. 7 ). Anchoring of heme within the substrate-binding pocket occurs through interaction of the heme propionate groups with exposed lysine and arginine residues (Unno et al. 2013; Wilks and Heinzl 2014; and reviewed in Wilks and Ikeda-Saito 2014) , and the central iron atom is coordinated by a conserved proximal histidine residue (H20) (Chu et al. 1999 (Chu et al. , 2000 . Degradation of heme is facilitated, in part, by a GXXXG catalytic motif and an ordered hydrogen-bonding network, which serves as a proton donor, features which are conserved amongst canonical HOs (Schuller et al. 1999; Unno et al. 2013) . While the finite mechanistic details of heme degradation fall outside the scope of this review, conversion of heme to biliverdin occurs through a series of oxidoreductive reactions (reviewed in Wilks and Heinzl 2014; Wilks and Ikeda-Saito 2014) . Notably, the catalytic turnover of both canonical and non-canonical HOs requires the activity of a reductase; to date, no such reductase has been identified in C. diphtheriae to reconstitute activity of HmuO.
Non-canonical heme monooxygenases
A paucity of potential HO homologs in bacteria outside of Corynebacterium spp., N. meningitidis and P. aeruginosa led to a search for proteins capable of fulfilling this function in Gram-positive pathogens such as St. aureus. Two putative hemedegrading enzymes, IsdG and its paralog, IsdI, were identified in St. aureus based on sequence similarity to a family of monooxygenases capable of oxidizing aromatic polyketides (an activity consistent with heme degradation), and on their association with the Isd heme acquisition pathway (Sciara et al. 2003; Skaar, Gaspar and Schneewind 2004) . Despite lacking significant sequence similarity to canonical HOs, IsdG and IsdI were indeed shown capable of cleaving the heme tetrapyrrole to release iron (Skaar, Gaspar and Schneewind 2004) . Although initially reported to degrade heme to biliverdin Schneewind 2004, 2006) , IsdG-like enzymes are now known to convert heme to a mixture of chromophoric 5-oxo-δ-bilirubin and 15-oxo-β-bilirubin, collectively referred to as the 'staphylobilins' (Fig. 7) (Reniere et al. 2010) . Additionally, unlike canonical HOs, which release a meso carbon atom in the form of CO, degradation of heme by IsdG and IsdI instead yields formaldehyde (Matsui et al. 2013) . The unique degradation products of IsdGlike HOs suggest a novel mechanism by which iron is released from heme by these proteins.
Distinct from canonical HOs, IsdG-like HOs are homodimeric proteins, which adopt a ferredoxin-like fold and form a β-barrel at the dimer interface (see Fig. 7 ) (Wu et al. 2004) . Both IsdG and IsdI possess two separate active sites each bearing an NWH catalytic triad on either side of the β-barrel; heme is coordinated in a deep hydrophobic cleft by propionate groups that form salt bridges with two arginine residues and a conserved histidine (H) residue that binds the central iron atom (Lee et al. 2008) . Opposite the aforementioned histidine, a conserved asparagine (N) residue essential for enzymatic activity purportedly serves to stabilize reaction intermediates and enhance the reactivity of IsdG/IsdI for heme (Wu et al. 2004; Lee et al. 2008) . Unlike with canonical HOs, binding of heme to IsdG and IsdI results in severe distortion to the planarity of the porphyrin ring, an effect referred to as 'heme ruffling' (Lee et al. 2008) . Ruffling is mediated by a conserved tryptophan (W) residue and is proposed to enhance the reactivity of IsdG and IsdI for heme, alter the regioselectivity of these enzymes relative to canonical HOs, and eliminate the need for the catalytic hydrogen-bonding network found in classic HOs (Lee et al. 2008; Takayama et al. 2011; Ukpabi et al. 2012) . Steric distortion induced by ruffling promotes oxidative cleavage at either the β-or δ-meso carbon, allowing for the production of the two different staphylobilins, and precluding the release of CO (Lee et al. 2008; Matsui et al. 2013 ), a potentially toxic metabolite for the staphylococci (Nobre et al. 2007; Tavares, Nobre and Saraiva 2012) . While the intracellular fate of formaldehyde and the staphylobilins has not been characterized, it is probable that IsdG-type heme-degrading enzymes are employed in organisms where the endogenous production of CO is unfavorable (Matsui et al. 2013) . Further investigation is required to identify potential biological roles for these unique heme degradation products.
IsdG homologs have been characterized in a number of Gram-positive pathogens including B. anthracis (Skaar, Gaspar and Schneewind 2006) and St. lugdunensis , which each possess a single known heme-degrading enzyme. In L. monocytogenes, an Isd-type heme-degrading enzyme (Isd-LmHde, formerly Lmo2213) has been identified; however, this protein lacks both the asparagine and histidine of the conserved catalytic triad, bears an elongated N-terminal region relative to IsdG and exists as a monomer instead of a homodimer (Duong et al. 2014) . Isd-LmHde reportedly degrades heme to iron and biliverdin, and while CO is not thought to be a degradation product of this enzyme, the fate of the α-meso carbon has not yet been identified (Duong et al. 2014) . A heme-degrading enzyme of similar structure to Isd-LmHde was previously identified in B. subtilis (HmoB); however, the catalytic triad remains conserved in this enzyme and its degradation products are comparable to that of IsdG (Park, Choi and Choe 2012, 2014) . Together these findings suggest that IsdG-type proteins represent a novel and potentially diverse group of heme-degrading enzymes. Genome sequence analysis has revealed putative IsdGtype enzymes in widely varied bacterial classes including α-, β-and γ -proteobacteria, Actinobacteria and Deinococci , suggesting that heme degradation by non-canonical HOs may be more pervasive than currently appreciated.
The sustained heme-degradative activity of IsdG-like enzymes, as with canonical HOs, requires molecular oxygen and a dedicated source of electrons (i.e. a reductase). To date, the only reductase known to interact with non-canonical HOs is the iron utilization oxidoreductase (IruO) of St. aureus, where it catalyzes the transfer of electrons from NADPH to IsdG and IsdI (Loutet et al. 2013a) . Notably, IruO-induced in vitro heme degradation occurs more rapidly with IsdI than IsdG, suggesting that the latter may utilize an as yet unidentified reductase. While the in vivo role of IruO in heme-iron acquisition has not been determined, putative IruO orthologs have been identified in a number of Gram-positive pathogens with IsdGtype heme monooxygenases, including St. lugdunensis, B. anthracis and L. monocytogenes, suggesting that IruO may also contribute to heme-iron utilization in these organisms (Loutet et al. 2013a) .
It should be noted that heme-degrading enzymes, canonical or non-canonical, have broader functionality than simply the liberation of iron from heme. Expression of the paralogous IsdG and IsdI enzymes of St. aureus has been shown to be differentially regulated by iron and heme, where both IsdG and IsdI are transcriptionally regulated by iron and Fur, but the former is further regulated post-translationally by heme ). An amino acid motif forming a flexible loop within IsdG, absent in IsdI, is a critical determinant in targeting IsdG for degradation in the absence of heme, through an unknown mechanism (Reniere, Haley and Skaar 2011) . It has been proposed that differential regulation of these heme-degrading enzymes allows for the fine-tuning of heme homeostasis within the cell, where IsdI promotes the liberation of iron from heme during early stages of infection, prior to significant erythrocyte lysis, and IsdG helps alleviate the risk of toxicity once heme has accumulated intracellularly . Indeed, IsdG of B. anthracis has been shown to promote growth in the presence of both limiting and excess concentrations of heme, suggesting that not only do IsdG-type enzymes function in heme-iron utilization, they also help confer protection against heme-mediated toxicity (Skaar, Gaspar and Schneewind 2006) . Finally, and perhaps most notably, the expression of hmuO in C. diphtheriae is repressed by DtxR and iron, but activated by heme and hemoglobin through two two-component regulatory systems, which serve to stringently control intracellular heme concentrations (Schmitt 1997a) . Several mechanisms exist to alleviate the toxic effects of heme, and include limiting uptake through heme-specific transporters, enhancing degradation through the expression of HOs, and reducing endogenous synthesis, all of which necessitate the coordinated effort of elaborate heme-sensing systems.
ALLEVIATING HEME TOXICITY: TWO-COMPONENT SYSTEM REGULATION OF HEME METABOLISM AND EFFLUX
Heme is toxic to bacteria at high concentrations and, as such, stringent control is required to maintain homeostatic concentrations of heme by regulating its import, export, synthesis and degradation in the face of changing environmental concentrations. The exact mechanism of heme toxicity is unknown and may be multifaceted, but is likely due in part to oxidative damage incurred by DNA through heme-generated ROS (Anzaldi and Skaar 2010; Wakeman et al. 2012 Wakeman et al. , 2014 . Heme homeostasis is maintained in the Gram-positive pathogens through the concerted activity of three functionally conserved mechanisms. Firstly, the uptake of heme-iron through the pathways discussed above (and summarized in Table 2 ) is repressed in the presence of excess iron through Fur in the staphylococci, Listeria spp. and Bacillus spp. (Xiong et al. 2000; Ledala et al. 2007 Ledala et al. , 2010 Torres et al. 2010; Gaballa and Helmann 2011) , DtxR in C. diphtheriae (Schmitt, Talley and Holmes 1997; Kunkle and Schmitt 2003; Allen and Schmitt 2009; Allen, Burgos and Schmitt 2013) and MtsR in the streptococci (Bates et al. 2005; Hanks et al. 2006; Toukoki et al. 2010) . Secondly, canonical and non-canonical heme oxygenases promote heme degradation and iron release as a means of both alleviating heme toxicity and liberating iron for cellular processes. Lastly, heme-sensing systems respond to changing heme concentrations through regulating the efflux of excess intracellular heme.
The observation that hmuO is tightly repressed under high iron conditions by DtxR but activated by heme and hemoglobin raised the possibility of a DtxR-independent, heme-iron-dependent means of regulating gene expression in C. diphtheriae (Schmitt 1997a) . Indeed, heme-dependent activation of hmuO was shown to be mediated by the corynebacterium heme-responsive sensor and activator, chrS and chrA, and to a lesser extent by the heme-responsive regulator sensor and activator, hrrS and hrrA (Schmitt 1999; Bibb et al. 2005; Bibb, Kunkle and Schmitt 2007) . ChrAS and HrrAS are both twocomponent signal transduction pathways each consisting of, as their names imply, a membrane-bound sensor kinase (ChrS and HrrS), and a cytoplasmic response regulator (ChrA and HrrA) (Schmitt 1999; Bibb et al. 2005; Bibb, Kunkle and Schmitt 2007) . Heme-dependent transcriptional activation of hmuO occurs through a phosphotransfer mechanism, which to date has not been interrogated in HrrAS, but likely unfolds in a manner similar to ChrAS signal transduction. Upon detecting excess heme through unknown means, ChrS is autophosphorylated at a conserved histidine residue (H215) within a transmembrane 'sensor domain' (Schmitt 1999; Bibb and Schmitt 2010) . Activated ChrS subsequently transfers its phosphate group to a conserved aspartate residue (D50) on ChrA (Bibb and Schmitt 2010; Burgos and Schmitt 2012) , which likely induces a conformational change in the response regulator that renders it proficient for DNA binding. Phosphorylated ChrA then binds a specific direct repeat recognition sequence within the promoter region of heme-responsive genes, which induces their transcription (Schmitt 1999; Bibb and Schmitt 2010) . Notably, the binding site for ChrA upstream of hmuO overlaps that of DtxR by 8 bp, suggesting that these two transcriptional regulators may compete for binding under high-iron conditions in the presence of heme, allowing for the fine-tuned regulation of both intracellular iron and heme concentrations (Burgos and Schmitt 2012) . In addition to hmuO, ChrAS is known to regulate two other loci implicated in heme metabolism: hemA which is involved in heme synthesis and is repressed by both HrrAS and ChrAS, and the heme-regulated transporter, HrtAB (Bibb, Kunkle and Schmitt 2007; Bibb and Schmitt 2010; Burgos and Schmitt 2012) .
The analysis of cytoplasmic protein profile changes in response to heme, iron and Fur in St. aureus first lead to the identification of HrtA, a putative ATPase whose expression is dramatically upregulated in response to heme, independent of iron or Fur (Friedman et al. 2006) . HrtA is encoded from a twogene operon, hrtAB, which along with the permease HrtB comprises a proposed heme-efflux pump. The expression of hrtAB in St. aureus is regulated by a dedicated two-component hemesensing system (HssRS) analogous to ChrAS in C. diphtheriae (Stauff, Torres and Skaar 2007; Stauff and Skaar 2009 ). Like ChrS, HssS senses excess heme and/or a heme metabolite and activates HssR through a phosphorelay cascade, the latter of which, like ChrA, binds a direct repeat in the promoter region of hrtAB Stauff and Skaar 2009 ). While little homology exists between ChrAS of C. diphtheriae and HssRS of St. aureus, and the sequences employed in DNA recognition and binding by ChrA and HssR are fundamentally different (Burgos and Schmitt 2012) , both ChrAS and HssRS are responsible for the regulation of hrtAB homologs in their respective organisms. HrtAB functions to alleviate heme toxicity purportedly through expulsion of excess heme, and direct demonstration of heme efflux by an orthologous transporter was shown recently in Lactococcus lactis (Lechardeur et al. 2011 Torres et al. 2007; Stauff and Skaar 2009; Wakeman et al. 2014) . Given their essentiality in heme metabolism, it is unsurprising that hrtAB-hssRS orthologs are widely distributed amongst the Firmicutes and, in addition to the organisms discussed above, are found in both pathogenic and commensal Staphylococcus spp., L. monocytogenes, S. agalactiae and Enterococcus faecalis Bibb and Schmitt 2010; Juárez-Verdayes et al. 2012) .
Surprisingly, despite its high hemolytic potential and the resulting likelihood of encountering free heme, S. pyogenes does not encode any clear homologs of hssRS-hrtAB. Instead, it appears that heme sensing and export in this pathogen are mediated by a porphyrin-regulated efflux regulon, pefRCD, which was first characterized in the group B streptococcus, S. agalactiae (Fernandez et al. 2010; Sachla et al. 2014) . Induced in response to heme stress, pefRCD encodes a heme-dependent transcriptional repressor (PefR), and an ABC-type heme exporter (PefCD) that together aid in the avoidance of heme toxicity in S. agalactiae (Fernandez et al. 2010; Sachla et al. 2014) . PefR binds both heme and iron-free protoporphyrin IX (PPIX), and it is proposed that like in S. agalactiae, binding of heme (or PPIX) to this regulator derepresses transcription of pefCD in S. pyogenes, thereby facilitating heme or PPIX efflux in this bacterium (Fernandez et al. 2010; Sachla et al. 2014 ). PefRCD has not yet been functionally characterized in S. pyogenes, and thus it is not yet known how this heme-responsive regulon mediates heme tolerance in this bacterium, nor whether pefRCD contributes to the survival of S. pyogenes in vivo.
TRANSFERRIN-IRON ACQUISITION
Siderophores
Siderophores are low molecular weight (typically <1 kDa), ferric iron-chelating molecules, produced and secreted by bacteria in response to iron deprivation. The affinity of siderophores for ferric iron, with binding constants as high as 10 −52 M (Carrano and Raymond 1979) , affords them the capacity to scavenge residual free iron from the environment, as well as expropriate it from host glycoproteins, such as transferrin and lactoferrin. The expression of siderophores, therefore, represents a commonly employed strategy by both Gram-negative and Grampositive pathogens to access extracellular host iron, and a vast array of structurally distinct, but often related, siderophores exists, with over 250 structures recently cataloged (Hider and Kong 2010) . Broadly, siderophores are classified based on the functional groups involved in iron coordination, and include catecholate, hydroxamate and α-hydroxycarboxylate types, as well as 'mixed type' siderophores when more than one brand of coordinating moiety is employed (Fig. 8 ) (reviewed in Miethke and Marahiel 2007) . The iron-regulated synthesis of siderophores usually occurs through one of two mechanisms, characterized based on the requirement, or lack thereof, for large multimodular enzyme platforms referred to as nonribosomal peptide synthases (NRPS). NRPS-based siderophore synthesis involves an assembly line of NRPS domains that activate and incorporate non-proteinogenic amino acids and their derivatives into an elongating chain, in the absence of an RNA template (Crosa and Walsh 2002) . In addition to siderophore synthesis, NRPS strategies are also employed in the production of antimicrobial peptides (Garcia-Gonzalez et al. 2014 ) and antibiotics, including daptomycin (Miao et al. 2005) and penicillin (Schofield et al. 1997) .
In contrast, NRPS-independent siderophore (NIS) synthesis occurs through the condensation of alternating dicarboxylic acids, diamines, amino alcohols or alcohols through synthetase enzymes that catalyze amide or ester bond formation between these siderophore subunits (Challis 2005) . Notably petrobactin, a siderophore produced by pathogenic Bacillus spp., employs a highly unusual hybrid NRPS/NIS siderophore synthesis pathway (Cendrowski, MacArthur and Hanna 2004) , the significance of which is discussed in subsequent sections.
Staphyloferrin A and staphyloferrin B
In response to iron starvation, two α-hydroxycarboxylate-type siderophores may be produced by the staphylococci: staphyloferrin A and/or staphyloferrin B. The biosynthesis of staphyloferrin A and staphyloferrin B has been well characterized within the last decade, and the enzymes for the generation and export of the two staphyloferrins are encoded from the loci sfaABCD Cotton, Tao and Balibar 2009 ) and sbnABCDE-FGHI, respectively Cheung et al. 2009 ). Both staphyloferrin A and staphyloferrin B coordinate iron through citrate-based moieties (Fig. 8) , where staphyloferrin A is assembled from two units of citrate that are linked by a central D-ornithine backbone (Cotton, Tao and Balibar 2009) . Condensation of the citrate molecules with D-ornithine is catalyzed by NIS synthetases SfaB and SfaD, which are sufficient to reconstitute functional staphyloferrin A in vitro in the presence of the aforementioned substrates and ATP (Cotton, Tao and Balibar 2009) . SfaC is a putative pyridoxal 5 -phosphate(PLP)-dependent amino acid racemase, which functions ostensibly to catalyze the formation of D-ornithine from its antipode prior to incorporation into the siderophore Cotton, Tao and Balibar 2009) . Notably, the staphyloferrin A-encoding locus lacks a dedicated citrate synthase and, consequently, citrate for staphyloferrin A production is derived from the TCA cycle citrate synthase, CitZ (Sheldon, Marolda and Heinrichs 2014) . Efflux of apo-staphyloferrin A is mediated by SfaA, a membrane transport protein of the major facilitator superfamily (MFS), where disruption of sfaA abrogates export of the siderophore, resulting in its intracellular accumulation (Hannauer, Sheldon and Heinrichs 2015) . While functionally similar to staphyloferrin A, staphyloferrin B is a chemically distinct siderophore assembled by three NIS synthetases, SbnCEF, from one unit each of citrate and α-ketoglutarate (α-KG) and two units of L-2,3-diaminopropionate (L-Dap) (Cheung et al. 2009 ). SbnH is a PLP-dependent carboxylase, which also aids in the assembly of functional staphyloferrin B by decarboxylating the biosynthetic intermediate β-citryl-2,3-diaminopropionic acid to citryl-diaminoethane, allowing for subsequent incorporation of the second L-Dap unit (Cheung et al. 2009 ). Recent investigations into the staphyloferrin B biosynthetic pathway have revealed that all of the aforementioned precursor molecules (L-Dap, α-KG and citrate) can be derived under iron restriction from gene products of sbnA-I (Beasley, Cheung and Heinrichs 2011; Cheung, Murphy and Heinrichs 2012; Kobylarz et al. 2014b; Sheldon, Marolda and Heinrichs 2014) . While SbnA and SbnB were previously shown essential to the production of L-Dap, and indeed to the production of functional staphyloferrin B in vitro (Beasley, Cheung and Heinrichs 2011) , the biosynthetic pathway for this important precursor of both siderophores and antibiotics was recently (Hannauer, Sheldon and Heinrichs 2015) . Expression of the biosynthetic loci for staphyloferrin A and staphyloferrin B is iron regulated through Fur and, indeed, consensus sequences for Fur binding (Fur boxes) are located in the non-coding region between sfaABC and sfaD , and upstream of sbnA-I . In addition to iron-dependent regulation, the elaboration of staphyloferrin A is also strongly linked to central metabolism, as production of this siderophore relies upon precursor citrate gleaned from the TCA cycle (Sheldon, Marolda and Heinrichs 2014) . Interestingly, and somewhat paradoxically, while CitZ is required for staphyloferrin A synthesis under iron restriction, these conditions also induce a global metabolic rearrangement known as the 'ironsparing response' which reduces expression of non-essential iron-containing pathways, including the TCA cycle, while concurrently upregulating glycolytic and fermentative metabolism (Friedman et al. 2006; Gaballa et al. 2008; Smaldone et al. 2012) . Production of staphyloferrin A is further confounded in glucosecontaining media, as carbon catabolite repression stringently suppresses TCA cycle activity in favor of glycolysis (Collins and Lascelles 1962; Strasters and Winkler 1963; Seidl et al. 2009 ). The production of staphyloferrin A, therefore, is severely hampered in iron-limited, glucose-containing media, whereas the synthesis of staphyloferrin B is unencumbered under these conditions due, in part, to the activity of SbnG (Sheldon, Marolda and Heinrichs 2014) .
The concentration of glucose in human serum (approximately 5.0 mM, and up to 11.1 mM in diabetics) is adequate to repress staphyloferrin A synthesis in vitro (Psychogios et al. 2011; American Diabetes Association 2013; Sheldon, Marolda and Heinrichs 2014) , suggesting that staphyloferrin A may not be the primary siderophore expressed during staphylococcal bacteremia. Conversely, all of the precursors to staphyloferrin B biosynthesis can be derived through the metabolism of glucose and L-glutamine (Psychogios et al. 2011; Sheldon, Marolda and Heinrichs 2014) , two of the four most prevalent metabolites in human serum (Psychogios et al. 2011) . Moreover, the loci for staphyloferrin B biosynthesis (sbnA-I) and transport (sirABC) are amongst the most robustly upregulated within Figure 9 . Staphyloferrin A contributes to the formation of staphylococcal skin abscesses. BALB/c mice were injected subcutaneously on the right flank with 1.5-2.0 × 10 7 CFU of St. aureus Newman WT, sbn, sfa or sfa sbn (n of six mice per strain). An sbn mutant is defective for staphyloferrin B synthesis, while an sfa mutant is defective for staphyloferrin A synthesis. Photographs of each abscess were taken every 24 h and the abscess area was quantified using Image J. Data are representative of two independent experiments. Statistical significance was determined relative to the sbn mutant using a two-way ANOVA, where * * * * P < 0.0001, * * * P < 0.001 and * * P < 0.01.
the iron-restricted host (Friedman et al. 2006; . It is not wholly surprising, given the aforementioned findings, that staphyloferrin B production is largely limited to the coagulase-positive staphylococci while, in contrast, the locus-encoding staphyloferrin A is widely distributed amongst both coagulase-positive staphylococci and the commonly commensalistic and only opportunistically pathogenic CoNS. Together, recent observations support a role for staphyloferrin A that is more conducive to promoting colonization and SSTIs than invasive infections, especially given that glucose and iron concentrations on the skin are lower, and higher, respectively, than in the serum and may therefore support TCA cycle activity, and hence staphyloferrin A synthesis (Beamish, Jobbins and Cavill 1971; Aruoma et al. 1988; Forslind 2000; Adams et al. 2005; Psychogios et al. 2011; Krismer et al. 2014) . To test this hypothesis, a murine skin abscess model was employed where mice were injected subcutaneously with 1.5-2.0 × 10 7 colony-forming units (CFU) of wild-type St. aureus strain Newman, or its isogenic mutants deficient in the production of staphyloferrin A, staphyloferrin B or both. The data demonstrate that St. aureus strains unable to synthesize staphyloferrin A are significantly impaired for subcutaneous abscess formation, relative to both the wildtype and staphyloferrin B-deficient strains (Fig. 9) , suggesting that staphyloferrin A expression may indeed help to facilitate skin colonization and infection by the staphylococci. Notably, no statistically significant reduction in staphylococcal burden or virulence has previously been observed for single-locus deletion mutants of either staphyloferrin biosynthesis or transport in a commonly employed murine bacteremia model, although combinatorial mutations that fully abrogate either of these two functions do contribute to staphylococcal survival in vivo . In contrast, these preliminary findings represent, to our knowledge, the first in vivo demonstration of impaired staphylococcal fitness in the absence of staphyloferrin A synthesis, and indeed the first investigation into the role of staphylococcal siderophores in a non-invasive infection model. Further investigation is required to elucidate the relationship between localized host metabolite concentrations, chiefly iron and glucose, and the respective roles of staphyloferrin A and staphyloferrin B in staphylococcal pathogenicity within these microenvironments. The production of two siderophores with differential expression within a given pathogen is not unusual, as with bacillibactin and petrobactin in B. anthracis and other members of the B. cereus group, and may indeed be a reflection of niche adaptation and virulence potential (Cendrowski, MacArthur and Hanna 2004; Wilson et al. 2010) . Subsequent to export, staphyloferrin A and staphyloferrin B solubilize and bind iron from precipitated ferric hydroxides in the extracellular environment, or strip iron from host transferrin and/or lactoferrin. Uptake of ferrated staphyloferrin A or staphyloferrin B occurs by way of the dedicated ABC-type transporters HtsABC (initially described as a heme-transport system) and SirABC (for staphylococcal iron-regulated), respectively, whose encoding genes are located adjacent to, but transcribed divergently from, the biosynthetic loci of their cognate siderophores (Heinrichs et al. 1999; Beasley et al. 2009 ). Both HtsBC and SirBC represent the heterodimeric permease components of these transporters, which are energized to transport ferric-staphyloferrin complexes through the activity of a non-dedicated and genetically unlinked ATPase, FhuC (Speziali et al. 2006; Beasley et al. 2009 ). As previously reviewed, HtsA and SirA are iron-regulated, cluster A-II (class III) substrate-binding lipoproteins (IRLPs; hereafter simply referred to as substrate-binding proteins), with a bilobate structure comprised of two independently folded α/β domains linked by a long α-helical spine (Berntsson et al. 2010 ; for a detailed review of staphylococcal substrate-binding proteins, see Sheldon and Heinrichs 2012) . Ferric siderophores are coordinated in a shallow, basic, cleft formed between the two lobes of HtsA and SirA, respectively, and while HtsABC (as the name implies) was previously implicated in heme-iron acquisition , it is unlikely that the binding pocket of HtsA also coordinates heme Grigg et al. 2010a, b) . A dual role for the HtsBC permease in heme and Festaphyloferrin A acquisition has not, however, been conclusively disproven.
Although staphyloferrin A and staphyloferrin B are both anionic, α-hydroxycarboxylate-type siderophores, their transporters are not substitutable, as HtsABC is dedicated to the transport of Fe-staphyloferrin A, and SirABC is dedicated to the transport of Fe-staphyloferrin B Cheung et al. 2009 ). The exquisite selectivity of SirA and HtsA for their cognate ferric siderophores, with affinities in the nanomolar range (Grigg et al. 2010a,b) , suggests that these substratebinding proteins must possess exacting means of coordinating Fe-staphyloferrin B and Fe-staphyloferrin A complexes, respectively. Recent resolution of the crystal structures for both apoand holo-HtsA paved the way for the interrogation of the specific residues involved in staphyloferrin A coordination Grigg et al. 2010b) . Four key residues, R104, R126, H209 and R306, have been identified as essential to Fe-staphyloferrin A binding (Cooper et al. 2014) . Three of these residues, R104, R126 and R306, are clustered together within the HtsA-binding pocket and form a positively charged platform upon which Festaphyloferrin A is coordinated through the terminal carboxyl moieties of citrate (Fig. 10 ). An additional key contact is formed between H209 and the carbonyl group on the ornithine backbone of the more deeply buried citrate, which, like the arginine residues, is highly conserved amongst HtsA orthologs. De- spite the high conservation of these residues, the sequence similarity between SirA and HtsA (∼32%), and the structural resemblance between these two ferric-siderophore receptors, only one coordinating residue is conserved between SirA and HtsA (R125 and R126, respectively) (Grigg et al. 2010a; Cooper et al. 2014) . The lack of conserved residues between SirA and HtsA, differential orientation of their associated siderophores within the binding pocket (the long axis of Fe-staphyloferrin B is oriented perpendicularly to the protein domain interface in SirA, whereas Fe-staphyloferrin A is rotated 90
• relative to this), and distinct conformational changes induced in the C-terminal domains of these proteins upon ligand binding are all likely to contribute to the high degree of specificity these receptors possess for their cognate ferric siderophores. While this specificity precludes SirA and HtsA from functioning broadly in the uptake of exogenous siderophores, it may serve the organism well for the high-affinity acquisition of low amounts of staphyloferrin A and staphyloferrin B in the extracellular milieu and further may render the staphylococci competitive against other organisms attempting to appropriate staphyloferrin A and staphyloferrin B to meet their own iron demands (Grigg et al. 2010a,b) . As with other substrate-binding proteins, the docking and subsequent uptake of holo-HtsA and holo-SirA is mediated by salt bridges formed between conserved glutamic acid residues on each domain of the substrate-binding proteins (E110 and E250 in HtsA, E109 and E245 in SirA), and positive patches comprised of three conserved arginine/lysine residues on the exofacial side of their respective permeases (Borths et al. 2002; Grigg et al. 2010a; Cooper et al. 2014) . Specific reductions in the interglutamic acid distance upon ligand binding by HtsA and SirA is proposed to help the associated permease distinguish between apo-and holo-forms of these receptor proteins (Grigg et al. 2010a ).
Bacillibactin and petrobactin
Two siderophores may potentially be produced and/or utilized by B. anthracis and B. cereus, the catecholate-type siderophore bacillibactin (formerly known as anthrabactin) and the mixedtype catecholate-carboxyl siderophore petrobactin (formerly known as anthrachelin) (Cendrowski, MacArthur and Hanna 2004; Garner, Arceneaux and Byers 2004; Koppisch et al. 2005; Wilson et al. 2006) . While both bacillibactin and petrobactin coordinate iron fully (bacillibactin) or partially (petrobactin) through dihydroxylbenzoic acid (DHBA) moieties, they differ in the hydroxylation pattern of this catechol group and are structurally distinct (Fig. 8 ). Bacillibactin is a cyclic trimer, comprised of glycine, threonine and three 2,3-DHBA moieties (May, Wendrich and Marahiel 2001; Koppisch et al. 2005) , the latter of which represents the most common iron-coordinating unit employed by catechol-type siderophores (Miethke and Marahiel 2007 ). In contrast, petrobactin is a linear molecule consisting of two spermidine arms, a central citrate unit and two unusual 3,4-DHBA moieties (Garner, Arceneaux and Byers 2004; Koppisch et al. 2005) , where the coordination of iron is performed by both citrate and 3,4-DHBA. Outside of petrobactin and its sulfonated derivatives (Barbeau et al. 2002; Gardner et al. 2004; Hickford et al. 2004; Homann et al. 2009 ), 3,4-DHBA is not found in any other siderophore, and has profound implications for host-pathogen interactions. The biosynthetic pathways for bacillibactin and petrobactin Pfleger et al. 2007 ) have been extensively characterized since their initial identification in B. subtilis (May, Wendrich and Marahiel 2001) and the unrelated hydrocarbondegrading, marine bacterium Marinobacter hydrocarbonoclasticus (Barbeau et al. 2002) , respectively. For a detailed summary of siderophore biosynthesis in Bacillus spp., the reader is referred to a comprehensive review by Hotta et al. (2010) and recent work by Sherman and colleagues (Nusca et al. 2012) . Bacillibactin and petrobactin are encoded from the bacillus anthracis catechol (bacACEBF, also known as dhbACEBF) locus and the anthrax siderophore biosynthesis (asbABCDEF) locus, respectively (Cendrowski, MacArthur and Hanna 2004; Wilson et al. 2006; Lee et al. 2007; Pfleger et al. 2007 ). While bacillibactin is synthesized exclusively through NRPSs (May, Wendrich and Marahiel 2001) , petrobactin assembly occurs through both NRPS (AsbC, AsbD and AsbE) and NIS-type enzymes (AsbA and AsbB), as well as a 3-dehydroshikimate/3,4-DHBA synthase (AsbF), the latter of which is responsible for synthesis of the unique 3,4-DHBA moiety (Cendrowski, MacArthur and Hanna 2004; Lee et al. 2007; Oves-Costales et al. 2007 , 2008 Pfleger et al. 2007 Pfleger et al. , 2008 Fox et al. 2008; Oves-Costales, Song and Challis 2009) . Notably, petrobactin is photoreactive and decarboxylates upon sustained exposure to light, where the resulting photoproduct binds iron with higher affinity than the siderophore itself (Barbeau et al. 2002; Abergel, Zawadzka and Raymond 2008a) . Further, both B. anthracis and B. cereus secrete free 3,4-DHBA and this metabolite, as well as the petrobactin photoproduct, are also purportedly capable of functioning as siderophores (Barbeau et al. 2002; Garner, Arceneaux and Byers 2004; Abergel, Zawadzka and Raymond 2008a; Zawadzka et al. 2009b) .
The production of bacillibactin and petrobactin may be an imperfect reflection of pathogenicity where, like with the staphyloferrins, one siderophore is more heavily implicated in virulence, at least in some types of infection niches, than the other. Similar to staphyloferrin A in the staphylococci, bacillibactin is widely expressed by Bacillus spp. including commensal or environmental isolates such as B. subtilis (May, Wendrich and Marahiel 2001; , B. licheniformis and B. amyloliquefaciens (He et al. 2012) . In contrast, the expression of petrobactin (akin to staphyloferrin B) is often limited to pathogenic members of the B. cereus group Hotta et al. 2010) . Given that select non-pathogenic Bacillus isolates express petrobactin, production of this siderophore alone cannot be used to determine virulence potential. However, pivotal work by Cendrowski, MacArthur and Hanna (2004) demonstrated that petrobactin, but not bacillibactin, is required for growth in iron-restricted media, survival and proliferation within macrophages, and for maximal virulence in a murine model of inhalational anthrax. Indeed, all known mammalian pathogens of the B. cereus group do express and require petrobactin for virulence (Cendrowski, MacArthur and Hanna 2004; Koppisch et al. 2005 Hotta et al. 2010) , and thus distinct biological roles have been proposed for bacillibactin and petrobactin in the B. anthracis life cycle.
Anthrax begins with the germination and outgrowth of B. anthracis spores within host macrophages, a process that requires iron. Temporal variation in the expression of the anthrax siderophores, where production of petrobactin precedes that of bacillibactin by several hours during outgrowth, suggests that petrobactin is the sole siderophore mediating iron acquisition during this early intracellular infection stage (Wilson et al. 2010) . Notably, conditions that mimic those likely encountered within the host, specifically growth at 37
• C and in the presence of CO 2 /bicarbonate (relative to growth at 23 • C and in the absence of CO 2 /bicarbonate), constrain bacillibactin production while petrobactin secretion is unencumbered (Koppisch et al. 2005; Wilson et al. 2010) . Additionally, petrobactin continues to be produced at iron concentrations inhibitive to bacillibactin elaboration, suggesting that iron more stringently regulates the production of the latter (Lee et al. , 2011 Wilson et al. 2010) . Together these findings clearly support the assertion that petrobactin is the more biologically relevant siderophore in the mammalian host, especially given its capacity to evade the activity of siderocalin . The role of bacillibactin in B. anthracis physiology has yet to be determined experimentally, but may facilitate iron acquisition late in the infectious process, during the transition from vegetative growth to sporulation (Wilson et al. 2010) , or in host niches inaccessible to siderocalin. Interestingly, bacillibactin was recently shown to be involved in the acquisition of intracellular ferritin iron. In addition to its putative role in heme-iron acquisition, IlsA purportedly functions as a ferritin receptor, and may disrupt the structural integrity of the ferritin nanocage, thereby promoting the release of iron from within the mineralized core (Daou et al. 2009; Segond et al. 2014 ). Bacillibactin but not petrobactin facilitates uptake of iron from ferritin through IlsA (Segond et al. 2014) , which suggests that there may yet be an important role for this siderophore in vivo, particularly in non-mammalian hosts which lack siderocalin (Segond et al. 2014) .
The means of bacillibactin and petrobactin secretion by B. cereus group members has not yet been investigated and to date no transporter has been identified for apo-petrobactin efflux. Given the conservation of bacillibactin production in Bacillus spp., it is likely that efflux of this siderophore occurs through the same mechanism in the majority of species, namely the MFS family efflux protein, YmfE (YmfD in B. anthracis) , initially identified and characterized in B. subtilis (Miethke, Schmidt and Marahiel 2008) . Notably, unlike all other aspects of bacillibactin synthesis and utilization, secretion of the siderophore does not appear to be Fur regulated, as YmfE is instead induced by the Mer-type multi-drug efflux activator Mta, although the exact mechanism of this regulation is unknown (Miethke, Schmidt and Marahiel 2008) .
Recent investigations into ferric siderophore uptake by B. anthracis (and other members of the B. cereus group) have helped to elucidate the means by which Fe-petrobactin and other exogenous siderophores are transported back into the cell. Through biochemical analysis, two receptor proteins, FatB and FpuA, were initially identified as binding Fe-petrobactin (and its derivatives) (Zawadzka et al. 2009b) , although only FpuA was found to mediate uptake of the ferric-siderophore complex (Carlson et al. 2010) . Indeed, disruption of fpuA is sufficient to severely attenuate growth of B. anthracis in iron-deplete media and virulence in a murine inhalational model (Carlson et al. 2010) , where the defects are comparable to those seen in petrobactin synthesis-deficient strains (Cendrowski, MacArthur and Hanna 2004; Lee et al. 2007) . While not synthesizing petrobactin, B. subtilis reportedly uses a FatB homolog, YclQ (FpiA) and its associated ABC transporter YclNOP (FpiBCD) for exogenous acquisition of Fe-petrobactin and its ferric photoproduct, although the biological implications of this are unclear (Zawadzka et al. 2009a; Bugdahn et al. 2010) . Further, FatB of B. anthracis is capable of binding free 3,4-DHBA with approximately 100-fold higher affinity than Fe-petrobactin, suggesting FatB may be involved in the uptake of this iron-loaded metabolite (Zawadzka et al. 2009b) ; however, further investigation is required to clearly elucidate the function of FatB in Bacillus spp. iron metabolism.
Unlike staphyloferrin A and staphyloferrin B, each of which bear a single, dedicated transporter, the uptake of Fe-petrobactin is mediated by three composite ABC transporters, that each employ the promiscuous FpuA as their substrate-binding protein (Dixon et al. 2012) . Two of these Fe-petrobactin transporters are comprised of FpuA working in concert with the FpuB permease, and one of two possible ATPases, FpuC or FpuD (FpuA/FpuBC and FpuA/FpuBD, respectively). The third Fe-petrobactin importer is comprised of FpuA, the FatCD permease and the FatE ATPase (FpuA/FatCDE) (Dixon et al. 2012) . While it is evident that these systems are at least partly functionally redundant for the uptake of Fe-petrobactin, it is unclear whether they are concurrently expressed and utilized, whether different affinities exist between the permeases for FpuA or whether they are capable of transporting other substrates, all notions requiring further investigation. As with the efflux of bacillibactin, the import of Fe-bacillibactin has not been directly investigated in members of the B. cereus group, but is presumed to occur through the conserved ABC transporter FeuABCD (FeuABC and the ATPase YusV 2 , in B. subtilis) (Miethke et al. 2006; Ollinger et al. 2006) . In B. subtilis, FeuABC is subject to substrate-dependent regulation, where transcription of feuABC is induced in the presence of Figure 11 . FeuA-bacillibactin structure. The ribbon structure of FeuA is shown colored from N-terminus (blue) to C-terminus (red) (PDB 2WHY). Highlighted are the residues, in stick format, from FeuA that interact with the bacillibactin backbone. Carbons, nitrogens and oxygens are colored yellow, blue and red, respectively, for the indicated FeuA side chains, and green, blue and red, respectively, for the bacillibactin molecule. The iron centre is shown as a red sphere.
bacillibactin (as well as enterobactin) through the bacillibactin transport regulator, Btr. In this unique system of one-component regulation, Fur derepresses the transcription of btr when iron is limiting, allowing for the AraC family transcriptional regulator to be expressed. Btr, in turn, binds a direct repeat upstream of feuABC, where binding is enhanced in the presence of the catecholate-type siderophores, thereby promoting their uptake (Gaballa and Helmann 2007) . Notably, substrate-dependent regulation of siderophore transport (and/or synthesis) may not be a phenomenon limited to B. subtilis; however, this notion has not been examined further in the Gram-positive pathogens.
As indicated by its regulation by both bacillibactin and enterobactin, FeuABC is not specific to bacillibactin uptake and is capable of transporting other catecholate-type siderophores (Miethke et al. 2006; Gaballa and Helmann 2007; Peuckert et al. 2009 ). In an effort to elucidate the means by which different catechol substrates are coordinated by FeuA, the structures of this substrate-binding protein in complex with bacillibactin, enterobactin and a synthetic enterobactin analog (mecam) were recently solved. Coordination of ferric siderophores by FeuA is mediated by a triad of basic residues (similar to siderophore coordination by siderocalin) composed of K84 and K105 on the NTD of the bilobate protein, and R180 on the C-terminal domain (Fig. 11) (Peuckert et al. 2009 (Peuckert et al. , 2011 . Additional coordination is provided, to a lesser extent, through hydrogen bonds formed between the ligand and residues Q181 and Q215 on the C-terminal domain of FeuA (Peuckert et al. 2011) . As with siderocalin, siderophore coordination occurs through electrostatic interactions between the positively charged basic triad and negatively charged ferric triscatecholates which, in conjunction with flexibility in hydrogen bonding, allows for the accommodation of various catechol motif-containing substrates (Goetz et al. 2000; Peuckert et al. 2009 Peuckert et al. , 2011 . In contrast to other class III substratebinding proteins, large conformational changes are observed between apo-FeuA and holo-FeuA; however, the changes induced upon siderophore binding are similar regardless of the substrate bound (Peuckert et al. 2011) . The distinct conformational changes between apo-and holo-FeuA, as with other substratebinding proteins, is proposed to position conserved glutamic acid residues (E90 and E221) on the siderophore receptor for interaction with conserved arginine residues on the permease components FeuB (R59) and FeuC (R53) (Peuckert et al. 2011) . Energy for the translocation of the ferric siderophore is provided by YusV 2 in B. subtilis or by the purportedly co-transcribed FeuD ATPase in B. cereus group members (Miethke et al. 2006; Ollinger et al. 2006) . Subsequent to transport, iron is released from Febacillibactin and Fe-enterobactin complexes through hydrolysis mediated by the cytosolic ferric bacillibactin esterase, BesA (YuiI), which is capable of cleaving both siderophores and is widely conserved in Bacillus spp. (Miethke et al. 2006; Abergel et al. 2009 ). In contrast, enterobactin-producing bacteria utilize the ferric enterobactin esterase, Fes, which is exclusive for this siderophore (O'Brien, Cox and Gibson 1971; Brickman and McIntosh 1992; Abergel et al. 2009 ). The mechanism of iron release from Fe-petrobactin is not yet known.
Corynebactin
Evidence of siderophore production by C. diphtheriae was first presented in the mid-1980s Holmes 1983, 1985; Russell, Cryz and Holmes 1984) ; however, it was not until very recently that this siderophore, corynebactin, was fully purified and structurally characterized. To date, corynebactin is the sole known siderophore of C. diphtheriae, and as an α-hydroxycarboxylate-type siderophore comprised in part of two citrate molecules, it bears a stark resemblance to both staphyloferrin A of St. aureus, and rhizoferrin of the fungal pathogen Rhizopus microsporus var. rhizopodiformis (and other fungal and bacterial species) (Konetschny-Rapp et al. 1990; Meiwes et al. 1990; Bergeron et al. 1997) . In contrast to staphyloferrin A and rhizoferrin, where D-ornithine and putrescine form the siderophore backbone, respectively, the citrate moieties in corynebactin are linked by a central lysine residue (Zajdowicz et al. 2012) . The diphtherial siderophore is encoded by the DtxRregulated locus ciuABCDEFG (for corynebacterium iron uptake), where CiuA is purportedly a substrate-binding protein functioning in conjunction with the putative ABC transporter CiuBCD to internalize ferric corynebactin. Indeed, ciuA mutants are capable of secreting corynebactin, but are not able to utilize the secreted siderophore as an iron source, suggesting they are incapable of ferric-siderophore uptake. The only other gene of the corynebactin biosynthetic locus currently characterized is ciuE, which is required for the synthesis of the siderophore and allegedly functions as a NIS synthetase (Kunkle and Schmitt 2005; Zajdowicz et al. 2012 ). CiuE appears to be a fusion protein, bearing homology to both IucA and IucC, two aerobactin synthesis genes which function to catalyze amide bond formation between the dicarboxylic acid and diamine units of the siderophore (De Lorenzo et al. 1986 ). Further, sfaB and sfaD of the staphyloferrin A biosynthetic cluster also bear homology to IucA and IucC, suggesting that CiuE may perform functions analogous to SfaB and SfaD in the synthesis of the structurally similar corynebacterial siderophore. It is not yet known whether the N-and C-terminal regions of CiuE possess distinct enzymatic functions, nor how CiuE in whole contributes to corynebactin synthesis. Following synthesis, export of apo-corynebactin may be mediated by CiuF, a putative MFS-type efflux pump; however, the role of this protein has not yet been investigated. Lastly, the ability of corynebactin to function in removing iron from host glycoproteins has not yet been explored, nor is it known if C. diphtheriae produces an alternate siderophore, given that deletion of ciuE reduces, but does not abolish, growth under iron-deplete conditions (Kunkle and Schmitt 2005; Zajdowicz et al. 2012) .
STEALTH SIDEROPHORES
Consistent with the co-evolving interplay between the host and pathogens for control of valuable iron resources, means exist within the mammalian host for counteracting the production of siderophores by bacteria and, in turn, bacteria have ways of subverting this mechanism. Siderocalin [also known as lipocalin 2, lipocalin 24p3, neutrophil gelatinase-associated lipocalin (NGAL), superinducible protein 24 (SIP24), neu-related lipocalin (NRL0) and uterocalin] is a mammalian acute-phase protein secreted by neutrophils that aids in host nutritional immunity by sequestering bacterial siderophores (Goetz et al. 2002) . Apo-and ferric-siderophore coordination by siderocalin occurs within a cup-shaped ligand-binding site (calyx) which, relative to other lipocalins, is unusually broad, shallow and lined with atypical positively charged and polar residues (Goetz et al. 2000 (Goetz et al. , 2002 . The nature of the siderocalin calyx, therefore, dictates a specificity of this bacteriostatic agent for negatively charged ferric siderophores, such as the catecholates (Goetz et al. 2002) . Binding of siderocalin to these siderophores renders them inaccessible as iron-scavenging agents to invading bacteria.
The production of more than one siderophore of different classes is a common theme among pathogens and represents one mechanism by which the effects of siderocalin can be circumvented. Examples of this subversion tactic exist in Gram-negative and Gram-positive pathogens alike; among other illustrations, Escherichia coli and other enteric bacteria can produce the catecholate enterobactin as well as the mixed citratehydroxamate aerobactin (Gibson and Magrath 1969; Pollack, Ames and Neilands 1970; , Salmonella enterica serovars and uropathogenic E. coli commonly express both enterobactin and glucosylated enterobactin derivatives referred to as salmochelins (Hantke et al. 2003; Bister et al. 2004; Fischbach et al. 2006; Müller, Valdebenito and Hantke 2009) and, most relevant to this discussion, pathogenic B. anthracis and B. cereus isolates are known to produce both bacillibactin and petrobactin (Cendrowski, MacArthur and Hanna 2004; Garner, Arceneaux and Byers 2004; Koppisch et al. 2005; Wilson et al. 2006) . Ultimately these pairings reflect a siderocalinsusceptible siderophore (e.g. a catecholate) and a siderocalinimmune siderophore (e.g. a hydroxamate-based, citrate-based, or structurally modified siderophore), suggesting that the latter evolved to evade the innate immune defense of siderocalin. While 2,3-DHBA-containing siderophores such as bacillibactin and enterobactin are capable of appropriating iron from transferrin (Raymond, Dertz and Kim 2003; Dertz et al. 2006) , these siderophores are readily bound and effectively inactivated by siderocalin, raising questions about their relevance in vivo (Goetz et al. 2002; Flo et al. 2004; Hoette et al. 2008; Abergel et al. 2008b) . In contrast, the bulky C-glucosylation of salmochelin and the position of the carboxylates in 3,4-DHBA of petrobactin renders these siderophores sterically discordant for binding by siderocalin (Hantke et al. 2003; Bister et al. 2004; Abergel et al. 2006; Fischbach et al. 2006; Hoette et al. 2008) . The ability of siderophores such as petrobactin and salmochelin to subvert the antibacterial effects of siderocalin through unusual structural modifications thus earned them the designation of 'stealth siderophores' . Similarly, other pathogens, such as St. aureus and C. diphtheriae simply elaborate one or more siderophores (the staphyloferrins and corynebactin, respectively) that lack aromatic-binding motifs and instead coordinate iron through hydroxamate or citrate moieties that form neutral ferric complexes not coordinated by siderocalin (Goetz et al. 2002; Hoette et al. 2008) .
XENOSIDEROPHORES
In addition to endogenous siderophore production and utilization, some bacteria are able to appropriate siderophores secreted by other organisms; insofar as the recipient bacterium is concerned, these are known as 'xenosiderophores'. Acquisition of xenosiderophores often occurs through the elaboration of uptake pathways with broad specificity for iron-loaded hydroxamate, catechol or α-hydroxycarboxylate-type siderophores, instead of any one specific siderophore. In this manner, bacteria capable of acquiring exogenous siderophores may have a competitive advantage within heterogeneous bacterial populations, where they are able to parasitize multiple potential ironchelating molecules as an iron source without the energetic demands involved in their synthesis and secretion (Guan, Kanoh and Kamino 2001; Joshi, Archana and Desai 2006; D'Onofrio et al. 2010; Miethke, Kraushaar and Marahiel 2013; Brozyna, Sheldon and Heinrichs 2014) . Indeed pathogens such as St. lugdunensis (Brozyna, Sheldon and Heinrichs 2014) and L. monocytogenes (Jin et al. 2006; Xiao et al. 2011) , for example, are dependent upon the uptake of xenosiderophores to access the transferriniron pool. In the Gram-positive pathogens, the acquisition of xenosiderophores occurs through both distinct and highly conserved pathways.
Acquisition of hydroxamate xenosiderophores-Fhu and others
The uptake of hydroxamate siderophores in many bacteria occurs by way of the conserved ferric hydroxamate uptake system, Fhu. Aside of Gram-negative bacteria such as E. coli, and among the Gram-positive pathogens described in this review, the Fhu system has been most extensively characterized in St. aureus. Homologs have been identified in L. monocytogenes, (Jin et al. 2006; Xiao et al. 2011) , the B. cereus group (Ollinger et al. 2006; Zawadzka et al. 2009b) and S. pyogenes (Hanks et al. 2005; Li et al. 2013) . While functionally similar, these Fhu systems exhibit varying substrate specificities, interacting partners and degrees of characterization to date. Additionally, alternate mechanisms of ferric-hydroxamate uptake have been suggested for both the B. cereus group and C. diphtheriae.
In the staphylococci, which are unable to synthesize endogenous-hydroxamate siderophores, Fhu is comprised of two heterodimeric permease units (FhuBG), a promiscuous ATPase (FhuC 2 ), and two paralogous and partially redundant substrate-binding proteins, FhuD1 and FhuD2 (Sebulsky and Heinrichs 2001; Sebulsky et al. 2003 Sebulsky et al. , 2004 Speziali et al. 2006) . FhuD2 facilitates the uptake of a wide variety of hydroxamatetype siderophores, including ferrichrome, desferrioxamine B, aerobactin and coprogen (Sebulsky and Heinrichs 2001; Podkowa et al. 2014) , whereas FhuD1 appears to accommodate a restricted subset of these siderophores (e.g. ferrichrome and desferrioxamine B), although it is possible that additional substrates of, or conditions mediating uptake by, FhuD1 have yet to be identified (Sebulsky and Heinrichs 2001; Sebulsky et al. 2003 Sebulsky et al. , 2004 . Both FhuD1 and FhuD2 are cluster A, class III substrate-binding proteins (Berntsson et al. 2010) which bind their respective siderophores with micromolar to nanomolar affinity, respectively (Sebulsky et al. 2003 Mariotti et al. 2013) . The ability of FhuD2 to coordinate several different hydroxamate ligands was recently attributed to two key interacting residues, R199 and W197, which form a hydrogen-bonding network with the structurally conserved hydroxamate groups of the siderophore (notably these two residues are also conserved in FhuD1) (Mariotti et al. 2013; Podkowa et al. 2014) . In contrast, a ring of largely aromatic residues in FhuD2 accommodates the unconserved aliphatic regions of the siderophore, such that both conserved and non-conserved features of the siderophore are coordinated, as has similarly been shown for FhuD of E. coli (Clarke et al. 2000 (Clarke et al. , 2002 Mariotti et al. 2013; Podkowa et al. 2014) . Binding of a given siderophore induces minor, but distinct, conformational changes in the substrate-binding protein (Sebulsky et al. 2003; Mariotti et al. 2013; Podkowa et al. 2014) , and it is not yet known how this variation between apo-and holo-forms influences the docking of FhuD2 (or FhuD1) with FhuBGC 2 . However, as with other substrate-binding proteins and their respective permeases, the interaction between FhuD2 and FhuBG is mediated by salt bridges formed between conserved glutamic acid residues on FhuD2 (E97 and E231) and conserved basic residues on FhuB and FhuG (R71 and R61, respectively) (Sebulsky et al. 2003; Mariotti et al. 2013; Vinés, Speziali and Heinrichs 2014) .
Staphylococcal FhuD2 has attracted attention in recent years as a potential vaccine target, owing in part to the lack of substantial conformational changes in the protein upon ligand binding allowing for well-ordered epitopes for vaccine targeting, and its known expression in vivo (Sebulsky et al. 2003; Mishra et al. 2012; Mariotti et al. 2013) . Indeed, FhuD2 is required for maximal proliferation within the blood and establishment of renal abscesses in a murine model of systemic infection (Mishra et al. 2012) . Vaccination with FhuD2 confers protection against staphylococcal infection in mice, both by promoting opsonophagocytic clearing and by inhibiting siderophore-mediated iron acquisition (Mishra et al. 2012; Mariotti et al. 2013) . The importance of Fhu in staphylococcal pathogenesis was further highlighted in a recent study, where it was demonstrated that administration of Desferal, a chelator employed in the treatment of iron-overload diseases and mesylate salt of desferrioxamine B, can exacerbate staphylococcal infections in mice, an effect which is abrogated in fhuG and fhuD1/D2 mutants (Arifin et al. 2014) . Given the capability of pathogens to use iron chelators as xenosiderophores, extreme discretion should be applied in administering these compounds when co-presentation of a bacterial infection is possible.
Listeria monocytogenes and S. pyogenes do not elaborate siderophores; however, both are capable of acquiring exogenous-hydroxamate siderophores through the activity of Fhu homologous systems. In L. monocytogenes, FhuD (LmoFhuD) is not duplicated and has broad specificity, similar to FhuD2 of St. aureus. As such, LmoFhuD mediates the uptake of ferrichydroxamate siderophores including ferrichrome, ferrichrome A and ferrioxamine B via FhuBGC (Jin et al. 2006; Xiao et al. 2011) with an affinity for its preferred substrate, ferrioxamine B, in the nanomolar range (Xiao et al. 2011) . LmoFhuD has also been implicated in the binding of other iron complexes including heme, ferric enterobactin and PPIX (Xiao et al. 2011) ; however, a role in transport of these substrates has not been defined.
In S. pyogenes, uptake of 55 Fe-ferrichrome was mediated by FtsABCD (for ferrichrome transporter system), where FtsB serves as the substrate-binding protein, and FtsA and FtsCD as the ATPase and permease components, respectively (Hanks et al. 2005; Li et al. 2013) . The residues responsible for hydroxamate coordination are conserved between St. aureus FhuD1/D2 and S. pyogenes FtsB (W204 and Y137) (Li et al. 2013) , suggesting that like FhuD2, FtsB may function broadly in the uptake of hydroxamate siderophores. Interestingly, however, mutation of the same transporter, known also as SiuADBG, resulted in decreased growth in the presence of blood, serum and hemoglobin, and decreased virulence in a zebrafish infection model (Montanez, Neely and Eichenbaum 2005) , and further studies are required to elucidate the identity of its preferred substrate(s). Members of the B. cereus group possess ferric-hydroxamate acquisition systems for the uptake of a plethora of different siderophores that are both similar to, and distinct from, the Fhu system employed by the staphylococci. In addition to expressing a canonical FhuCBG transporter and a solitary FhuD substrate-binding protein for the acquisition of ferrichrome, B. cereus and B. subtilis both express a second substrate-binding protein, YxeB, which interacts with the same permease for the uptake of both ferrichrome and ferrioxamine (Ollinger et al. 2006; Zawadzka et al. 2009b) . Notably, FhuCBG of B. cereus is capable of binding YxeB containing either apo-siderophores or ferric siderophores, but only facilitates uptake of the latter (Zawadzka et al. 2009b) . A novel siderophore shuttle mechanism was recently demonstrated in this pathogen, where YxeB bound to an apo-siderophore will preferentially receive iron from a ferric siderophore (without iron reduction), in lieu of being displaced by an iron-bound siderophore (Fukushima et al. 2013; Fukushima, Allred and Raymond 2014) . In this manner, aposiderophores can be concentrated at the cell surface to receive iron from associated ferric siderophores, poor iron chelators and free iron. While not investigated in other Gram-positive pathogens, this mechanism may be conserved in other bacteria where substrate-binding proteins are capable of binding both apo-and ferric siderophores.
Both B. cereus and B. subtilis are capable of utilizing the hydroxamate siderophore schizokinen, produced by the ubiquitous environmental bacterium B. megaterium (Mullis, Pollack and Neilands 1971) , as a sole iron source. Uptake of schizokinen (as well as arthrobactin in B. subtilis) occurs independent of Fhu and is mediated by the alternate substrate-binding protein YfiY; in B. subtilis, YfiY interacts with the putative transporter YfiZ/YfhA and the ATPase YusV 2 (Ollinger et al. 2006; Zawadzka et al. 2009b) . Detailed characterization of this hydroxamate system has not been performed, nor have any of the aforementioned systems been directly examined in B. anthracis.
Unlike all of the other Gram-positive pathogens, no functional Fhu homologs have been described in C. diphtheriae, consistent with its inability to broadly utilize hydroxamate siderophores. To date, the sole identified xenosiderophore of C. diphtheriae appears to be aerobactin, which is acquired through a transporter distinct from the one employed for corynebactin (CiuA) (Russell, Cryz and Holmes 1984; Zajdowicz et al. 2012; Schmitt 2014) . Uptake of aerobactin is proposed to occur through a sparsely characterized, iron-regulated ABC transporter, Irp6ABC, although further investigation is required to fully elucidate its function with respect to ferric-hydroxamate acquisition in C. diphtheriae (Qian, Lee and Holmes 2002; Schmitt 2014) .
Hydroxamate transporters have seen utility as mediators of entry of siderophore-drug conjugates into several different Gram-positive pathogens. For example, albomycin is a naturally occurring siderophore-drug (sideromycin) conjugate composed of a hydroxamate siderophore fused to an antibiotic moiety (Pramanik and Braun 2006; Pramanik et al. 2007 ). This concept is explored further in the 'Clinical Applications' section, below.
Acquisition of catecholate xenosiderophores-SstABCD and FeuABCD
Staphylococcus spp., Listeria spp. and Bacillus spp. are all capable of using exogenous catecholate siderophores, as well as ferrated catecholamine stress hormones such as epinephrine, norepinephrine and dopamine as 'pseudosiderophores' (Coulanges et al. 1997; Coulanges, Andre and Vidon 1998; Miethke et al. 2006; Ollinger et al. 2006; Zawadzka et al. 2009b; Miethke and Skerra 2010; . Catecholamines function as siderophores not by directly stripping iron from transferrin, but rather by first reducing Fe 3+ bound to transferrin to Fe 2+ ; the negligible affinity of transferrin for ferrous iron facilitates its release and allows for subsequent capture by the hormone (Sandrini et al. 2010) . Further, small catechol molecules are capable of forming 3:1 complexes with Fe 3+ , which structurally and functionally resemble bacterial triscatecholate siderophores (Jewett, Eggling and Geller 1997) . Indeed, in the presence of serum (which contains transferrin), catecholamines promote the growth of many bacteria including members of the staphylococci, B. subtilis and L. monocytogenes (Coulanges et al. 1997; Coulanges, Andre and Vidon 1998; Freestone et al. 2000 Freestone et al. , 2008 Neal et al. 2001; Lyte et al. 2003; Miethke and Skerra 2010; . The use of neurotransmitters as an iron source would represent a valuable asset to a pathogen with a penchant for the nervous system; however, no transporter has yet been characterized for these substrates in L. monocytogenes. It has long been hypothesized that L. monocytogenes expresses a broad specificity, cell-surface-associated ferric reductase that releases iron from extracellular complexes, such as catecholamines (Coulanges et al. 1997; Coulanges, Andre and Vidon 1998) , and while a ferric reductase was very recently identified (see the section 'Inorganic iron acquisition') its substrate specificity has not yet been defined (Tiwari et al. 2014) . In contrast, the uptake of catechol-type siderophores and catecholamine hormones is known to be mediated by the staphylococcal siderophore transporter, SstABCD and by FeuABCD(YusV 2 ), in the staphylococci and Bacillus spp., respectively. SstABCD is a highly conserved ABC-type transporter in the staphylococci, consisting of a requisite substrate-binding protein (SstD), two permease components (SstA and SstB) and a dedicated ATPase (SstC) (Morrissey et al. 2000) . SstD specifically binds both catecholamine hormones and catecholate siderophores with micromolar affinities . The lower affinity of SstD relative to substrate-binding proteins such as HtsA and SirA, each of which bind a specific siderophore with nanomolar affinity (Grigg et al. 2010a,b) , is likely a reflection of its ability to accommodate a more diverse range of substrates. In the absence of the obscuring effects of staphyloferrin A and staphyloferrin B production, catechol siderophores and catecholamine hormones do indeed enhance St. aureus growth in serum in an sstABCD-dependent manner . Although disruption of sstABCD did not significantly impact staphylococcal burden in the livers and kidneys of mice in a systemic infection model, it did compromise bacterial survival in the heart , suggesting that there are specific niches in which SstABCD plays a role in staphylococcal pathogenesis. While the staphylococci lack the proclivity of L. monocytogenes for nervous system tissue, concentrations of catecholamines high enough to subvert the bacteriostatic effects of transferrin and/or lactoferrin may be found at wound sites where neuronal damage has occurred, or in the gastrointestinal tract where transferrin, lactoferrin and heterogeneous bacterial populations (potentially releasing catechol siderophores) all coexist (Freestone et al. 2002; Markel et al. 2007 ). Further, conditions that exacerbate catecholamine levels in the host, including stress or therapeutic treatment, may enhance the risk of bacterial infection by pathogens capable of using these 'pseudosiderophores' (Eisenhofer et al. 1996; Freestone et al. 2002 Freestone et al. , 2008 .
In addition to bacillibactin, members of the B. cereus group acquire iron from both exogenous enterobactin and select catecholamine hormones, such as norepinephrine, using the transporter FeuABCD(YusV 2 ) (Miethke et al. 2006; Ollinger et al. 2006; Zawadzka et al. 2009b; Miethke and Skerra 2010) . Ferric-triscatecholate coordination by FeuA is, like siderocalin, mediated by a conserved triad of positively charged basic residues which interact with negatively charged catechol motifcontaining substrates (Goetz et al. 2000; Peuckert et al. 2009 Peuckert et al. , 2011 . The binding pocket of FeuA is rigid in both size and shape, which limits its specificity to substrates that are structurally similar in shape and charge to bacillibactin and enterobactin (Dertz et al. 2006; Peuckert et al. 2011) , although the range of accommodation has not been exhaustively tested. Indeed, the specificity of FeuA for its substrates (nanomolar to low micromolar range) is intermediate to HtsA/SirA and SstD (Dertz et al. 2006; Zawadzka et al. 2009b; Grigg et al. 2010a,b; Peuckert et al. 2011) , consistent with its limited promiscuity for catecholate motif-containing partners. Notably, while the biological role of FeuABCD has not yet been investigated, presumably this transporter would find the greatest utility in the gastrointestinal tract where pathogenic Bacillus spp. may usurp siderophores from enterobactin-producing members of the microbiotia.
Acquisition of α-hydroxycarboxylate-type xenosiderophores-Hts and Sir
In contrast to hydroxamate and catecholate-type siderophores, there does not appear to be a conserved or dedicated pathway for the uptake of α-hydroxycarboxylate xenosiderophores. Indeed, none of the Gram-positive pathogens are reportedly able to use such siderophores as a sole iron source, although the appropriation of α-hydroxycarboxylate-type siderophores has not been extensively tested. To date the best, and perhaps sole, characterization of α-hydroxycarboxylate xenosiderophore utilization is in St. lugdunensis, which is incapable of synthesizing staphyloferrins A or B, owing to a large deletion in the sfa locus and the lack of a staphyloferrin B-encoding locus, typical of the CoNS (Brozyna, Sheldon and Heinrichs 2014) . Interestingly, St. lugdunensis still retains the ability to exploit staphyloferrin A and staphyloferrin B as iron sources in an Hts-and Sir-dependent manner, respectively, and indeed co-culture of St. lugdunensis with an staphyloferrin A-and staphyloferrin B-proficient strain of St. aureus enhanced growth of the former (Brozyna, Sheldon and Heinrichs 2014) . Given that St. lugdunensis is frequently isolated concomitantly with other bacteria, including other staphylococci (Herchline and Ayers 1991) , it is possible that St. lugdunensis shrewdly evolved to steal siderophores from other bacteria frequenting similar host niches, a trait that may potentiate its opportunistic lifestyle.
INORGANIC IRON ACQUISITION
Due to the overshadowing effects of heme-and siderophorebased iron acquisition, and the relative lack abundance of bioavailable inorganic iron, acquisition systems for the uptake of free iron have been sparsely characterized, and their alleged substrates remain highly contentious in many cases. In anoxic, low pH (reducing) environments, ferrous iron may be directly imported by way of high-affinity ferrous iron transporters, whereas at neutral pH under aerobiosis, iron, prior to its uptake must first be reduced to its ferrous form by secreted, and often cell-associated, reductases. To date, three conserved inorganic iron transporters have been identified among the Gram-positive pathogens, the ferrous iron importer, FeoAB, an ABC-type divalent metal transporter often implicated in both manganese and ferrous iron acquisition (SitABC/MntABC/MtsABC), and a system analogous to the high-affinity, reductive, inorganic iron permease Ftr1p-Fet3p-Fre1p of Baker's yeast (reviewed in Kosman 2003; Kwok, Severance and Kosman 2006) .
Although FeoAB appears to be a highly conserved, ubiquitous, ferrous iron importer, this system is ill characterized in the Gram-positive pathogens. Feo was first identified in E. coli and, in this organism and other γ -proteobacteria, consists of a small hydrophilic, cytoplasmic protein of unknown function (FeoA), a bona fide ferrous iron permease (FeoB) and another small hydrophilic protein (FeoC) that bears a winged helix-turn-helix motif implicated in DNA binding, as well as a putative iron-sulfur cluster-binding site (Hantke 1987; Kammler, Schön and Hantke 1993; Cartron et al. 2006; Hung et al. 2012; Kim, Lee and Shin 2012) . FeoA purportedly interacts with the N-terminal cytoplasmic domain of FeoB, and indeed is required for FeoB-mediated uptake of ferrous iron in E. coli and Sa. enterica, although the exact function of this protein remains unknown (Kammler, Schön and Hantke 1993; Kim, Lee and Shin 2012) . While initially proposed to serve as a transcription factor (Cartron et al. 2006) , FeoC instead appears to function as a post-translational regulator of FeoB. The activity of FeoC protects FeoB from proteolytic degradation, and it has been suggested that iron-sulfur cluster binding to the former may serve as a redox and/or iron sensor mediating the availability of FeoB for iron import (Kim, Lee and Shin 2013) . Ferrous iron predominates in low oxygen, low pH environments and, indeed, expression of feoABC is induced under these conditions in a number of Gram-negative pathogens including E. coli O157:H7, Shigella flexneri and Sa. enterica (Boulette and Payne 2007; Cao et al. 2007; Kim, Lee and Shin 2013) . Homologs of feoAB have been identified in Staphylococcus spp., B. anthracis and L. monocytogenes, and small putative FeoC-like proteins are encoded within the feo gene cluster in these organisms (Cartron et al. 2006) . To date, the feoAB(C) locus has not been experimentally interrogated in any Gram-positive pathogen, although notably is upregulated during iron starvation in both St. aureus and L. monocytogenes in a Fur-dependent manner (Ledala et al. 2010 (Ledala et al. , 2014 Lin et al. 2012) . Future efforts in investigating the function of feoAB(C) should help shed light on how Gram-positive pathogens acquire inorganic iron in anaerobic and/or acidic environments where ferrous iron predominates and siderophores would likely be ineffective.
As with the uptake of heme and siderophores, the transport of free ferrous iron across the cytoplasmic membrane may also be facilitated by specific ABC-type transporters. The first such transporter to be identified in the Gram-positive pathogens was the presumptively named staphylococcal iron transporter, SitABC in St. epidermidis . The supposition that SitABC transports iron is supported by its robust in vivo expression under iron restriction (Williams, Denyer and Finch 1988; Smith et al. 1991; Wilcox et al. 1991; Modun et al. 1992) , and known regulation by both ferrous iron and manganese through the staphylococcal iron regulator repressor, SirR . In contrast, the sitABC homolog in St. aureus is a dedicated manganese transporter, mntABC (Horsburgh et al. 2002) , and thus the actual substrate of SitABC remains ambiguous. The streptococcal homolog of sitABC, mtsABC (metal transporter in streptococcus), is similarly regulated by both ferric iron and manganese in S. pyogenes (Hanks et al. 2006 (Janulczyk, Pallon and Björck 1999; Sun et al. 2008 Gribenko et al. 2013) . Indeed, MtsABC has only been implicated in manganese and, to a lesser extent, iron uptake (Janulczyk, Ricci and Björck 2003) . Notably, mtsABC is required for full virulence of S. pyogenes in a murine subcutaneous air sac model (Janulczyk, Ricci and Björck 2003) , although it is still unclear whether this impediment is due to reduced manganese uptake, iron uptake, or both, or a yet unassigned function to MtsABC. Listeria monocytogenes has long been known to express potent cell-surface-associated ferric reductase activity with a broad range of potential iron-containing substrates including catecholamine hormones and siderophores (Deneer, Healey and Boychuk 1995; Coulanges et al. 1997; Cowart 2002) . The potential capacity of Gram-positive pathogens to reduce ferric iron to ferrous iron is an often-overlooked mechanism of accessing insoluble ferric iron precipitates and non-specifically liberating iron from host complexes. Until very recently, no genetic determinant associated with ferric reductase activity had been identified in L. monocytogenes, due to a lack of clear conventional ferric reductase homologs in its genome. Despite a plethora of potential substrates, the iron acquisition systems of L. monocytogenes have been sparsely characterized. In an effort to help elucidate the means by which this pathogen obtains iron, a Fur-regulated locus bearing homology to the elemental ferrous iron uptake system, EfeUOB (Grosse et al. 2006) , of E. coli was recently investigated (Tiwari et al. 2014) .
Homologs of efeUOB are found widely distributed with high-sequence conservation in both Gram-negative and Gram-positive bacteria; however, the substrate of this transporter is a subject of debate in almost all cases where it has been characterized. In E. coli, efeUOB encodes a tripartite inorganic iron transporter, which has been implicated in both ferrous and ferric iron uptake, as well as heme-iron extraction, similar to its staphylococcal counterpart, fepABC (for Fe-dependent peroxidase) (Biswas et al. 2009; Letoffe et al. 2009; Turlin et al. 2013) . Listeria monocytogenes and B. subtilis also encode orthologs of this transporter, referred to as fepCAB and efeUOB, respectively, both implicated in the acquisition of inorganic iron Tiwari et al. 2014 ).
EfeU and FepC are both homologs of the ferric iron permease, Ftrp1 of Saccharomyces cerevisiae (Kwok, Severance and Kosman 2006; Cao et al. 2007; Turlin et al. 2013) , where EfeU in E. coli bears conserved RExxE motifs which have been implicated in ferrous iron transport (Grosse et al. 2006) . Indeed, EfeUOB in E. coli was shown to be required for ferrous iron uptake under iron restriction at low pH (Grosse et al. 2006; Cao et al. 2007) . EfeU purportedly receives iron from an uncharacterized substratebinding protein, EfeO (FepA), a member of the imelysin-like protein superfamily which bears a conserved sequence (GxHxxE) implicated in the binding of divalent metal cations (Rajasekaran et al. 2010a,b; Xu et al. 2011) . In E. coli, EfeO also possesses an N-terminal cupredoxin (Cup) domain and it has been proposed that this domain actually functions to re-oxidize ferrous iron gleaned from the environment prior to transport by EfeU (Rajasekaran et al. 2010a) . The third component of the tripartite iron transporter, EfeB, and its ortholog FepB are members of the Dye-decolorizing heme peroxidase (DyP) superfamily, and are transported as folded proteins across the cytoplasmic membrane by the twin-arginine translocase (Tat) system in E. coli, St. aureus, B. subtilis and L. monocytogenes (Jongbloed et al. 2004; Sturm et al. 2006; Biswas et al. 2009; van der Ploeg et al. 2011; Tiwari et al. 2014) .
Of the three components of EfeUOB/FepABC, the function of EfeB/FepB remains the most hotly contested. DyP family peroxidases have widely varied functions, and both E. coli and St. aureus members of this family (EfeB and YfeX, and FepB, respectively) have been ascribed a heme deferrochelatase activity, whereby iron is extracted from heme leaving the porphyrin ring intact (Letoffe et al. 2009; Turlin et al. 2013) . Structural characterization of EfeB in complex with heme and PPIX revealed that both molecules are coordinated at the same site in a manner similar to heme coordination by other DyP peroxidases, and that overexpression of EfeB from E. coli resulted in the accumulation of PPIX (Liu et al. 2011) . However, this proposed activity is contentious, and the rationale of PPIX production by cells has been questioned, as this by-product is both toxic and lacks a natural degradative pathway, and it has instead been suggested that EfeB/FepB oxidizes porphyrinogens to porphyrins (Dailey et al. 2011) .
In contrast, FepB in L. monocytogenes was most recently shown to have ferric iron reductase activity, although alternate substrates and interacting partners have not yet been investigated (Tiwari et al. 2014) . FepB functioning as a ferric reductase is not entirely incongruent with its suggested function as a deferrochelatase, the latter of which would require reduction of protoporphyrin iron to facilitate release. EfeB in B. subtilis, however, seems to retain typical DyP peroxidase activity and oxidizes ferrous iron to ferric iron . The literature to date suggests that FepB/EfeB may have evolved to facilitate access to iron sources frequently encountered in the particular niches that are occupied by different microbes. In the staphylococci, FepB may provide Isd-independent access to heme-iron. In B. subtilis, a facultative anaerobe that may frequently encounter low pH and/or anaerobic environments, EfeB may allow for the acquisition of free ferrous iron. In contrast, potent ferric reductase activity may be required by L. monocytogenes to pirate iron from catecholamines, xenosiderophores and transferrin. In a consolidated model, we put forth the notion that EfeUOB/FepABC serves as a dynamic, multifunctional ferric iron transporter evolved to suit the iron sources encountered by specific pathogens. Here, EfeB/FepB serves to modulate the oxidation state of iron before its transfer, through an unknown mechanism, to EfeO/FepA. In organisms lacking a Cup domain in EfeO/FepA, this protein likely serves to receive ferric iron, whereas those bearing such a domain may receive and re-oxidize ferrous iron, both of which are subsequently transferred to the membrane permease, EfeU/FepC.
CLINICAL APPLICATIONS AND FUTURE DIRECTIONS
In the face of constantly evolving antibiotic resistance, novel means of combating bacterial infections are desperately needed. The essentiality of iron to the survival and proliferation of all notable Gram-positive pathogens, coupled with the known expression of iron acquisition systems in vivo, makes these pathways attractive targets for therapeutic intervention. Broadly, exploiting iron-uptake mechanisms to the detriment of pathogenic bacteria typically involves one of three approaches: (i) utilizing substrate-binding proteins as vaccine antigens, (ii) inhibiting siderophore biosynthetic pathways or (iii) employing siderophore-uptake pathways to actively transport toxic molecules.
While vaccines exist against anthrax, diphtheria and streptococcal pneumonia, success in developing preventative treatments against other formidable Gram-positive pathogens, namely the staphylococci, has been limited. Efforts in developing an antistaphylococcal vaccine have focused, in part, on the use of IsdB and FhuD2 as antigens, and have been spearheaded by Merck and Novartis Pharmaceuticals, respectively. These proteins represent attractive targets for vaccine development due to their cell-surface exposure and in vivo expression, role in staphylococcal pathogenesis, and high degree of conservation in epidemiologically significant strains of St. aureus (Kuklin et al. 2006; Kim et al. 2010; Mishra et al. 2012) .
Early studies into the efficacy of IsdB as an immunogen revealed that vaccination of both rodents and non-human primates with this protein elicited the formation of protective antibodies and conferred partial resistance to staphylococcal infections in mice (Kuklin et al. 2006; Brown et al. 2009 ). Further, antibodies against IsdB (and IsdA) were shown to hinder in vitro heme-iron acquisition by St. aureus (Bubeck Wardenburg and Schneewind 2008; Kim et al. 2010) , suggesting a multifunctional role of these α-Isd antibodies in vivo. Phase I and IIa clinical trials of the human IsdB vaccine, V710, initially showed promising results in terms of safety and immunogenicity in both healthy volunteers and hemodialysis patients (Harro et al. 2010 (Harro et al. , 2011 Moustafa et al. 2012) . In a subsequent trial, however, V710 failed to reduce the incidence of post-operative staphylococcal disease in patients undergoing cardiothoracic surgery, and in fact was associated with increased mortality among subjects who did develop such an infection, although the reasons for this remain unknown (Fowler et al. 2013) . The V710 study has since been terminated, owing to a lack of efficacy and due to safety concerns.
Efforts are still ongoing to develop an antistaphylococcal vaccine; research through Novartis has shown that vaccination with FhuD2 generates protective immunity against St. aureus infection in mice, and that the derived antibodies promote opsonophagocytosis in vitro and may block ferrichydroxamate acquisition (Mishra et al. 2012; Mariotti et al. 2013) . However, as with IsdB, vaccination with purified recombinant FhuD2 or α-FhuD2 antibodies only conferred partial protection against staphylococcal infection in murine renal abscess and sepsis models (Mishra et al. 2012; Mariotti et al. 2013) . Greater protection may be afforded through use of a multivalent antistaphylococcal vaccine, where multiple cell-surface proteins are employed, as has previously been for combinatorial vaccination with IsdA, IsdB and two serine(S)-aspartate(D) repeat proteins of unknown function, SdrD and SdrE (Josefsson et al. 1998; Stranger-Jones, Bae and Schneewind 2006) . Accordingly, Syntiron LLC, through Sanofi-Pasteur, is working towards a staphylococcal vaccine using their patented 'siderophore receptor and porin proteins' (SRP) technology, which targets multiple in vivo surface-expressed substrate-binding proteins. As suggested by Syntiron, such an approach may provide broad crossprotection against other Gram-positive pathogens expressing similar iron transport proteins.
Siderophore production is a crucial virulence determinant in pathogens such as B. anthracis and is required for optimal survival and proliferation of others, such as St. aureus (Cendrowski, MacArthur and Hanna 2004; . The targeting of siderophore biosynthesis with small molecule inhibitors ultimately endeavors to further restrict iron availability to invading pathogens, thus hindering their replication within the host (Miethke and Marahiel 2007) . The recent and extensive characterization of siderophore biosynthetic pathways has prompted renewed interest in the development of novel bacteriostatic agents that target conserved catalytic mechanisms leading to siderophore production. SbnE and AsbA of the staphyloferrin B and petrobactin biosynthetic pathways, respectively, are both type A NIS enzymes, which catalyze the formation of an amide (or ester) bond between one of the prochiral carboxyl groups on citrate and a hydroxyl or amino group on another precursor molecule (Challis 2005; Oves-Costales et al. 2007; Cheung et al. 2009; Oves-Costales, Song and Challis 2009 ). Competitive inhibitors of these type A NIS enzymes were recently identified, baulamycin A (BmcA) and baulamycin B (BmcB), produced by Streptomyces tempisquensis, and shown to impede growth of B. anthracis and St. aureus under iron restriction (Tripathi et al. 2014) . Notably, these enzymes are conserved in the siderophore synthesis pathways of numerous bacteria including other staphyloferrin A-and/or staphyloferrin B-producing staphylococcal species, other petrobactin-producing B. cereus group members, and numerous aerobactin-producing enteric pathogens including E. coli, Sa. typhimurium and Sh. flexneri (Gibson and Magrath 1969; Oves-Costales et al. 2007; Cheung et al. 2009; Cotton, Tao and Balibar 2009; Oves-Costales, Song and Challis 2009 ), and indeed BmcA was shown to inhibit growth of many of these pathogens (Tripathi et al. 2014) . Inhibitors of type A NIS synthetases, and other conserved mechanisms of bacterial iron acquisition, therefore represent potential targets for broad-spectrum antibiotics.
Another promising avenue of combating antibiotic resistance in the Gram-positive pathogens is the further development of sideromycins. These siderophore-antibiotic conjugates employ a 'Trojan Horse' method of bacterial inhibition, whereby these molecules are actively transported into the cell through siderophore-uptake pathways. Accordingly, sideromycins are typically effective at lower doses than traditional antibiotics, which largely depend upon diffusion to enter the cell, and have the potential to function as broad-spectrum antimicrobials by employing conserved transport mechanisms and intracellular targets (Braun et al. 2009 ). Albomycin and salmycin are two natural derivatives of ferrichrome and ferrioxamine, respectively, which are transported by Fhu systems in both Gramnegative and Gram-positive bacteria (Pramanik and Braun 2006; Pramanik et al. 2007) . Once inside the cell, albomycin inhibits seryl t-RNA synthetase, whereas salmycin inhibits protein synthesis through an unknown mechanism (Vértesy et al. 1995; Stefanska et al. 2000) . Resistance to these sideromycins typically occurs through mutation of the siderophore transporter or the intracellular enzyme required to cleave, and thus activate, the antibiotic from the conjugate (Girijavallabhan and Miller 2004) . Although acquired resistance and the instability of salmycin likely preclude its use as an effective antibiotic in vivo (Braun et al. 2009 ), various synthetic derivatives have been produced of this sideromycin which have been shown effective at specifically targeting and inhibiting pathogens including St. aureus (Wencewicz et al. 2013) . A similar approach may eventually be applied in the use of toxic heme analogs, which engage hemeiron transporters of pathogens for uptake and inhibit bacterial respiration (Wakeman et al. 2014) . While this notion has not yet been explored in vivo, previous attempts to replace iron in siderophores with non-metabolizable metal ions has demonstrated that care must be taken to prevent metal toxicity within the host (Miethke and Marahiel 2007) .
CONCLUDING REMARKS
As detailed above, Gram-positive bacteria that cause significant morbidity and mortality in humans and animals have evolved sophisticated strategies with which to overcome the varied means by which the host sequesters iron. Outstanding efforts over the past decade by many laboratories have led to an incredible amount of new information in the field. This has helped propel basic science towards translation science, as evidenced by the efforts of pharma and biotech in using iron-regulated proteins as lead vaccine candidates. Indeed, many of these proteins have only been discovered during the past decade. The next decade promises to bring many new discoveries, but many challenges as well. A detailed understanding of how redundancy in iron acquisition mechanisms serves the pathogen during the various stages of infection, and how these intersect with the host innate immune mechanisms, is but one area that will be of primary interest for researchers in the coming years. This, of course, will impact on the success of any future therapeutics targeting aspects of iron acquisition/homeostasis.
